Form N-PX Tekla World Healthcare For: Jun 30
|
UNITED STATES |
OMB APPROVAL |
|
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB Number: 3235-0582 |
|
Expires: March 31, 2021 | |
|
Estimated average burden hours per response........7.2 |
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811- 06565
Tekla World Healthcare Fund
(Exact name of registrant as specified in charter)
100 Federal Street, 19th Floor, Boston, MA |
|
02110 |
(Address of principal executive offices) |
|
(Zip code) |
Laura Woodward
Tekla World Healthcare Fund
100 Federal Street, 19th Floor, Boston MA 02110
(Name and address of agent for service)
Registrants telephone number, including area code: 617-772-8500
Date of fiscal year end: September 30
Date of reporting period: 7/1/17-6/30/18
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrants proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (OMB) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.
Item 1. Proxy Voting Record.
THW Vote Summary
ABBOTT LABORATORIES
Security |
002824100 |
Meeting Type |
Annual |
Ticker Symbol |
ABT |
Meeting Date |
27-Apr-2018 |
Record Date |
28-Feb-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
R.J. Alpern |
|
|
|
For |
|
For |
|
|
|
2 |
R.S. Austin |
|
|
|
For |
|
For |
|
|
|
3 |
S.E. Blount |
|
|
|
For |
|
For |
|
|
|
4 |
E.M. Liddy |
|
|
|
For |
|
For |
|
|
|
5 |
N. McKinstry |
|
|
|
For |
|
For |
|
|
|
6 |
P.N. Novakovic |
|
|
|
For |
|
For |
|
|
|
7 |
W.A. Osborn |
|
|
|
For |
|
For |
|
|
|
8 |
S.C. Scott III |
|
|
|
For |
|
For |
|
|
|
9 |
D.J. Starks |
|
|
|
For |
|
For |
|
|
|
10 |
J.G. Stratton |
|
|
|
For |
|
For |
|
|
|
11 |
G.F. Tilton |
|
|
|
For |
|
For |
|
|
|
12 |
M.D. White |
|
|
|
For |
|
For |
|
2. |
|
Ratification of Ernst & Young LLP as Auditors |
|
Management |
|
For |
|
For |
| |
3. |
|
Say on Pay - An Advisory Vote to Approve Executive Compensation |
|
Management |
|
For |
|
For |
| |
4. |
|
Shareholder Proposal - Independent Board Chairman |
|
Shareholder |
|
For |
|
Against |
|
ABBVIE INC.
Security |
00287Y109 |
Meeting Type |
Annual |
Ticker Symbol |
ABBV |
Meeting Date |
04-May-2018 |
Record Date |
07-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
Roxanne S. Austin |
|
|
|
For |
|
For |
|
|
|
2 |
Richard A. Gonzalez |
|
|
|
For |
|
For |
|
|
|
3 |
Rebecca B. Roberts |
|
|
|
For |
|
For |
|
|
|
4 |
Glenn F. Tilton |
|
|
|
For |
|
For |
|
2. |
|
Ratification of Ernst & Young LLP as AbbVies independent registered public accounting firm for 2018 |
|
Management |
|
For |
|
For |
| |
3. |
|
Say on Pay - An advisory vote on the approval of executive compensation |
|
Management |
|
For |
|
For |
| |
4. |
|
Say When on Pay - An advisory vote on the frequency of the advisory vote to approve executive compensation |
|
Management |
|
1 Year |
|
For |
| |
5. |
|
Approval of a management proposal regarding amendment of the certificate of incorporation for the annual election of directors |
|
Management |
|
For |
|
For |
| |
6. |
|
Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting |
|
Management |
|
For |
|
For |
| |
7. |
|
Stockholder Proposal - to Issue an Annual Report on Lobbying |
|
Shareholder |
|
Against |
|
For |
| |
8. |
|
Stockholder Proposal - to Separate Chair and CEO |
|
Shareholder |
|
For |
|
Against |
| |
9. |
|
Stockholder Proposal - to Issue an Annual Compensation Committee Report on Drug Pricing |
|
Shareholder |
|
Against |
|
For |
|
ACADIA HEALTHCARE COMPANY, INC.
Security |
00404A109 |
Meeting Type |
Annual |
Ticker Symbol |
ACHC |
Meeting Date |
03-May-2018 |
Record Date |
09-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1.1 |
|
Election of Director: E. Perot Bissell |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election of Director: Vicky B. Gregg |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory vote on the compensation of the Companys named executive officers as presented in the Proxy Statement. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratify the appointment of Ernst & Young LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
ADAPTIMMUNE THERAPEUTICS PLC
Security |
00653A107 |
Meeting Type |
Annual |
Ticker Symbol |
ADAP |
Meeting Date |
20-Jun-2018 |
Record Date |
03-May-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
To re-elect as a director, Lawrence Alleva, who retires by rotation in accordance with the Articles of Association. |
|
Management |
|
For |
|
For |
|
2. |
|
To re-elect as a director, David Mott, who retires by rotation in accordance with the Articles of Association. |
|
Management |
|
For |
|
For |
|
3. |
|
To re-elect as a director, Elliott Sigal, who retires by rotation in accordance with the Articles of Association. |
|
Management |
|
For |
|
For |
|
4. |
|
To re-appoint KPMG LLP as our U.K. statutory auditors under the U.K. Companies Act 2006, to hold office until the conclusion of the next general meeting of shareholders at which the U.K. statutory accounts and reports are presented. |
|
Management |
|
For |
|
For |
|
5. |
|
To authorize the Audit Committee to determine our U.K. statutory auditors remuneration for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
6. |
|
To receive the U.K. statutory annual accounts and reports for ...(Due to space limits, see proxy material for full proposal). |
|
Management |
|
For |
|
For |
|
7. |
|
To receive and approve our U.K. statutory directors remuneration report for the year ended December 31, 2017. |
|
Management |
|
For |
|
For |
|
8. |
|
To receive and approve our Directors Remuneration Policy, which, if approved, will take effect upon conclusion of the Annual General Meeting. |
|
Management |
|
For |
|
For |
|
AETNA INC.
Security |
00817Y108 |
Meeting Type |
Special |
Ticker Symbol |
AET |
Meeting Date |
13-Mar-2018 |
Record Date |
05-Feb-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
To approve and adopt the Agreement and Plan of Merger, dated as of December 3, 2017, as it may be amended from time to time, among CVS Health Corporation, Hudson Merger Sub Corp. and Aetna Inc. (the merger agreement). |
|
Management |
|
For |
|
For |
|
2. |
|
To approve the adjournment from time to time of the Special Meeting of Shareholders of Aetna Inc. if necessary to solicit additional proxies if there are not sufficient votes to approve and adopt the merger agreement at the time of the Special Meeting of Shareholders of Aetna Inc. or any adjournment or postponement thereof. |
|
Management |
|
For |
|
For |
|
3. |
|
To approve, on an advisory (non-binding) basis, the compensation that will or may be paid or provided by Aetna Inc. to its named executive officers in connection with the merger of Hudson Merger Sub Corp. with and into Aetna Inc. |
|
Management |
|
For |
|
For |
|
AETNA INC.
Security |
00817Y108 |
Meeting Type |
Annual |
Ticker Symbol |
AET |
Meeting Date |
18-May-2018 |
Record Date |
16-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Fernando Aguirre |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Mark T. Bertolini |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Frank M. Clark |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Molly J. Coye, M.D. |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Roger N. Farah |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Jeffrey E. Garten |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Ellen M. Hancock |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Richard J. Harrington |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Edward J. Ludwig |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Olympia J. Snowe |
|
Management |
|
For |
|
For |
|
2. |
|
Company Proposal - Approval of the Appointment of the Independent Registered Public Accounting Firm for 2018 |
|
Management |
|
For |
|
For |
|
3. |
|
Company Proposal - Approval of the Companys Executive Compensation on a Non-Binding Advisory Basis |
|
Management |
|
For |
|
For |
|
4A. |
|
Shareholder Proposal - Annual Report on Direct and Indirect Lobbying |
|
Shareholder |
|
Against |
|
For |
|
4B. |
|
Shareholder Proposal - Special Shareholder Meeting Vote Threshold |
|
Shareholder |
|
Against |
|
For |
|
AFFIMED N.V
Security |
N01045108 |
Meeting Type |
Annual |
Ticker Symbol |
AFMD |
Meeting Date |
19-Jun-2018 |
Record Date |
22-May-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
5 |
|
Discussion of the 2017 Statutory Annual Report and proposal to adopt the financial statements for the financial year 2017, as prepared in accordance with Dutch law |
|
Management |
|
For |
|
For |
|
7 |
|
Amendment of the Remuneration Policy for the Supervisory Board (the SB Remuneration Policy) |
|
Management |
|
For |
|
For |
|
8 |
|
Discharge of the managing directors for their management during the financial year 2017 |
|
Management |
|
For |
|
For |
|
9 |
|
Discharge of the supervisory directors for their supervision during the financial year 2017 |
|
Management |
|
For |
|
For |
|
10a |
|
Appointment of: Dr. Mathieu Simon as a supervisory director |
|
Management |
|
For |
|
For |
|
10b |
|
Reappointment of: Dr. Ulrich M. Grau as a supervisory director |
|
Management |
|
For |
|
For |
|
11 |
|
Appointment of the auditor for the financial year 2018 |
|
Management |
|
For |
|
For |
|
12 |
|
Amendment of the articles of association |
|
Management |
|
For |
|
For |
|
13 |
|
Authorization to acquire shares |
|
Management |
|
For |
|
For |
|
ALEXION PHARMACEUTICALS, INC.
Security |
015351109 |
Meeting Type |
Annual |
Ticker Symbol |
ALXN |
Meeting Date |
08-May-2018 |
Record Date |
12-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
Felix J. Baker |
|
|
|
For |
|
For |
|
|
|
2 |
David R. Brennan |
|
|
|
For |
|
For |
|
|
|
3 |
Christopher J. Coughlin |
|
|
|
For |
|
For |
|
|
|
4 |
Deborah Dunsire |
|
|
|
For |
|
For |
|
|
|
5 |
Paul A. Friedman |
|
|
|
For |
|
For |
|
|
|
6 |
Ludwig N. Hantson |
|
|
|
For |
|
For |
|
|
|
7 |
John T. Mollen |
|
|
|
For |
|
For |
|
|
|
8 |
Francois Nader |
|
|
|
For |
|
For |
|
|
|
9 |
Judith A. Reinsdorf |
|
|
|
For |
|
For |
|
|
|
10 |
Andreas Rummelt |
|
|
|
For |
|
For |
|
2. |
|
Ratification of appointment by the Board of Directors of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm. |
|
Management |
|
For |
|
For |
| |
3. |
|
Approval of a non-binding advisory vote of the 2017 compensation paid to Alexions named executive officers. |
|
Management |
|
For |
|
For |
| |
4. |
|
To request the Board to require an independent Chairman. |
|
Shareholder |
|
For |
|
Against |
|
ALLERGAN PLC
Security |
G0177J108 |
Meeting Type |
Annual |
Ticker Symbol |
AGN |
Meeting Date |
02-May-2018 |
Record Date |
06-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Nesli Basgoz, M.D. |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Paul M. Bisaro |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Joseph H. Boccuzi |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Christopher W. Bodine |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Adriane M. Brown |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Christopher J. Coughlin |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Carol Anthony (John) Davidson |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Catherine M. Klema |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Peter J. McDonnell, M.D. |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Patrick J. OSullivan |
|
Management |
|
For |
|
For |
|
1k. |
|
Election of Director: Brenton L. Saunders |
|
Management |
|
For |
|
For |
|
1l. |
|
Election of Director: Fred G. Weiss |
|
Management |
|
For |
|
For |
|
2. |
|
To approve, in a non-binding vote, Named Executive Officer compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Companys independent auditor for the fiscal year ending December 31, 2018 and to authorize, in a binding vote, the Board of Directors, acting through its Audit and Compliance Committee, to determine PricewaterhouseCoopers LLPs remuneration. |
|
Management |
|
For |
|
For |
|
4. |
|
To renew the authority of the directors of the Company (the Directors) to issue shares. |
|
Management |
|
For |
|
For |
|
5A. |
|
To renew the authority of the Directors to issue shares for cash without first offering shares to existing shareholders. |
|
Management |
|
For |
|
For |
|
5B. |
|
To authorize the Directors to allot new shares up to an additional 5% for cash in connection with an acquisition or other capital investment. |
|
Management |
|
For |
|
For |
|
6. |
|
To consider a shareholder proposal requiring an independent Board Chairman, if properly presented at the meeting. |
|
Shareholder |
|
Against |
|
For |
|
AMERISOURCEBERGEN CORPORATION
Security |
03073E105 |
Meeting Type |
Annual |
Ticker Symbol |
ABC |
Meeting Date |
01-Mar-2018 |
Record Date |
02-Jan-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1A. |
|
Election of Director: Ornella Barra |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director: Steven H. Collis |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director: Douglas R. Conant |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Director: D. Mark Durcan |
|
Management |
|
For |
|
For |
|
1E. |
|
Election of Director: Richard W. Gochnauer |
|
Management |
|
For |
|
For |
|
1F. |
|
Election of Director: Lon R. Greenberg |
|
Management |
|
For |
|
For |
|
1G. |
|
Election of Director: Jane E. Henney, M.D. |
|
Management |
|
For |
|
For |
|
1H. |
|
Election of Director: Kathleen W. Hyle |
|
Management |
|
For |
|
For |
|
1I. |
|
Election of Director: Michael J. Long |
|
Management |
|
For |
|
For |
|
1J. |
|
Election of Director: Henry W. McGee |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory vote to approve the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
4. |
|
Approval of an amendment and restatement of the AmerisourceBergen Corporation 2011 Employee Stock Purchase Plan. |
|
Management |
|
For |
|
For |
|
5. |
|
Stockholder proposal, if properly presented, to urge the Board of Directors to adopt a policy that the Chairman of the Board be an independent director. |
|
Shareholder |
|
Against |
|
For |
|
6. |
|
Stockholder proposal, if properly presented, regarding the ownership threshold for calling special meetings of stockholders. |
|
Shareholder |
|
Against |
|
For |
|
7. |
|
Stockholder proposal, if properly presented, to urge the Board of Directors to adopt a policy to disclose certain incentive compensation clawbacks. |
|
Shareholder |
|
Against |
|
For |
|
8. |
|
Stockholder proposal, if properly presented, to urge the Board of Directors to report to stockholders on governance measures implemented related to opioids. |
|
Shareholder |
|
Against |
|
For |
|
AMGEN INC.
Security |
031162100 |
Meeting Type |
Annual |
Ticker Symbol |
AMGN |
Meeting Date |
22-May-2018 |
Record Date |
23-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Dr. Wanda M. Austin |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Mr. Robert A. Bradway |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Dr. Brian J. Druker |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Mr. Robert A. Eckert |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Mr. Greg C. Garland |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Mr. Fred Hassan |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Dr. Rebecca M. Henderson |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Mr. Frank C. Herringer |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Mr. Charles M. Holley, Jr. |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Dr. Tyler Jacks |
|
Management |
|
For |
|
For |
|
1k. |
|
Election of Director: Ms. Ellen J. Kullman |
|
Management |
|
For |
|
For |
|
1l. |
|
Election of Director: Dr. Ronald D. Sugar |
|
Management |
|
For |
|
For |
|
1m. |
|
Election of Director: Dr. R. Sanders Williams |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory vote to approve our executive compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
4. |
|
Stockholder proposal for an annual report on the extent to which risks related to public concern over drug pricing strategies are integrated into our executive incentive compensation. |
|
Shareholder |
|
Against |
|
For |
|
ANTHEM, INC.
Security |
036752103 |
Meeting Type |
Annual |
Ticker Symbol |
ANTM |
Meeting Date |
16-May-2018 |
Record Date |
09-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Lewis Hay, III |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Julie A. Hill |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Antonio F. Neri |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Ramiro G. Peru |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory vote to approve the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
4. |
|
To approve proposed amendments to our Articles of Incorporation to allow shareholders owning 20% or more of our common stock to call special meetings of shareholders. |
|
Management |
|
For |
|
For |
|
5. |
|
Shareholder proposal to allow shareholders owning 10% or more of our common stock to call special meetings of shareholders. |
|
Shareholder |
|
Against |
|
For |
|
ARDELYX, INC
Security |
039697107 |
Meeting Type |
Annual |
Ticker Symbol |
ARDX |
Meeting Date |
13-Jun-2018 |
Record Date |
20-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
William Bertrand, Jr. |
|
|
|
For |
|
For |
|
|
|
2 |
Annalisa Jenkins |
|
|
|
For |
|
For |
|
|
|
3 |
Jan M. Lundberg, Ph.D. |
|
|
|
For |
|
For |
|
2. |
|
To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst & Young, LLP as the independent registered public accounting firm of the Company for the fiscal year ended December 31, 2018. |
|
Management |
|
For |
|
For |
|
ASTRAZENECA PLC
Security |
046353108 |
Meeting Type |
Annual |
Ticker Symbol |
AZN |
Meeting Date |
18-May-2018 |
Record Date |
06-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
To receive the Companys Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2017 |
|
Management |
|
For |
|
For |
|
2. |
|
To confirm dividends |
|
Management |
|
For |
|
For |
|
3. |
|
To reappoint PricewaterhouseCoopers LLP as Auditor |
|
Management |
|
For |
|
For |
|
4. |
|
To authorise the Directors to agree the remuneration of the Auditor |
|
Management |
|
For |
|
For |
|
5a. |
|
Election of Director: Leif Johansson |
|
Management |
|
For |
|
For |
|
5b. |
|
Election of Director: Pascal Soriot |
|
Management |
|
For |
|
For |
|
5c. |
|
Election of Director: Marc Dunoyer |
|
Management |
|
For |
|
For |
|
5d. |
|
Election of Director: Genevieve Berger |
|
Management |
|
For |
|
For |
|
5e. |
|
Election of Director: Philip Broadley |
|
Management |
|
For |
|
For |
|
5f. |
|
Election of Director: Graham Chipchase |
|
Management |
|
For |
|
For |
|
5g. |
|
Election of Director: Deborah DiSanzo |
|
Management |
|
For |
|
For |
|
5h. |
|
Election of Director: Rudy Markham |
|
Management |
|
For |
|
For |
|
5i. |
|
Election of Director: Sheri McCoy |
|
Management |
|
For |
|
For |
|
5j. |
|
Election of Director: Nazneen Rahman |
|
Management |
|
For |
|
For |
|
5k. |
|
Election of Director: Shriti Vadera |
|
Management |
|
For |
|
For |
|
5l. |
|
Election of Director: Marcus Wallenberg |
|
Management |
|
For |
|
For |
|
6. |
|
To approve the Annual Report on Remuneration for the year ended 31 December 2017 |
|
Management |
|
For |
|
For |
|
7. |
|
To authorise limited political donations |
|
Management |
|
For |
|
For |
|
8. |
|
To authorise the Directors to allot shares |
|
Management |
|
For |
|
For |
|
9. |
|
To authorise the Directors to disapply pre-emption rights |
|
Management |
|
For |
|
For |
|
10. |
|
To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments |
|
Management |
|
For |
|
For |
|
11. |
|
To authorise the Company to purchase its own shares |
|
Management |
|
For |
|
For |
|
12. |
|
To reduce the notice period for general meetings |
|
Management |
|
For |
|
For |
|
13. |
|
To adopt new Articles of Association |
|
Management |
|
For |
|
For |
|
AVADEL PHARMACEUTICALS PLC
Security |
05337M104 |
Meeting Type |
Annual |
Ticker Symbol |
AVDL |
Meeting Date |
18-Jul-2018 |
Record Date |
15-May-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Craig R. Stapleton |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Michael S. Anderson |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Peter Thornton |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Geoffrey M. Glass |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Linda S. Palczuk |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify, in a non-binding vote, the appointment of Deloitte & Touche LLP as the Companys independent registered public auditor and accounting firm for the fiscal year ending December 31, 2018 and to authorize, in a binding vote, the Audit Committee of the Board to set the independent registered public auditor and accounting firm remuneration. |
|
Management |
|
For |
|
For |
|
3. |
|
To approve, on a non-binding advisory basis, the compensation of the named executive officers of the Company. |
|
Management |
|
For |
|
For |
|
4. |
|
To authorize the price range at which the Company can re-allot ordinary shares that it holds as treasury shares under Irish law. |
|
Management |
|
For |
|
For |
|
BAXTER INTERNATIONAL INC.
Security |
071813109 |
Meeting Type |
Annual |
Ticker Symbol |
BAX |
Meeting Date |
08-May-2018 |
Record Date |
15-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Jose (Joe) E. Almeida |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Thomas F. Chen |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: John D. Forsyth |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: James R. Gavin III |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Peter S. Hellman |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Munib Islam |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Michael F. Mahoney |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Stephen N. Oesterle |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Carole J. Shapazian |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Cathy R. Smith |
|
Management |
|
For |
|
For |
|
1k. |
|
Election of Director: Thomas T. Stallkamp |
|
Management |
|
For |
|
For |
|
1l. |
|
Election of Director: Albert P.L. Stroucken |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory Vote to Approve Named Executive Officer Compensation |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification of Appointment of Independent Registered Public Accounting Firm |
|
Management |
|
For |
|
For |
|
4. |
|
Stockholder Proposal - Independent Board Chairman |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
Stockholder Proposal- Right to Act by Written Consent |
|
Shareholder |
|
Against |
|
For |
|
BAYER AG
Security |
D0712D163 |
Meeting Type |
Annual General Meeting |
Ticker Symbol |
BAYRY |
Meeting Date |
25-May-2018 |
Record Date |
18-May-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1 |
|
PRESENTATION OF THE ADOPTED ANNUAL FINANCIAL STATEMENTS AND THE APPROVED CONSOLIDATED FINANCIAL STATEMENTS, THE COMBINED MANAGEMENT REPORT, THE REPORT OF THE SUPERVISORY BOARD AND THE PROPOSAL BY THE BOARD OF MANAGEMENT ON THE USE OF THE DISTRIBUTABLE PROFIT FOR THE FISCAL YEAR 2017, AND RESOLUTION ON THE USE OF THE DISTRIBUTABLE PROFIT |
|
Management |
|
For |
|
For |
|
2 |
|
RATIFICATION OF THE ACTIONS OF THE MEMBERS OF THE BOARD OF MANAGEMENT |
|
Management |
|
For |
|
For |
|
3 |
|
RATIFICATION OF THE ACTIONS OF THE MEMBERS OF THE SUPERVISORY BOARD |
|
Management |
|
For |
|
For |
|
4 |
|
SUPERVISORY BOARD ELECTION: MR. NORBERT WINKELJOHANN |
|
Management |
|
For |
|
For |
|
5 |
|
ELECTION OF THE AUDITOR FOR THE ANNUAL FINANCIAL STATEMENTS AND FOR THE REVIEW OF THE HALF-YEARLY AND INTERIM FINANCIAL REPORTS: DELOITTE GMBH WIRTSCHAFTSPRUEFUNGSGESELLSCHAFT |
|
Management |
|
For |
|
For |
|
BIOCLIN THERAPEUTICS, INC.
Security |
N/A |
Meeting Type |
Written Consent |
Ticker Symbol |
N/A |
Meeting Date |
27-Sep-2017 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Election of Director |
|
Management |
|
For |
|
For |
|
2. |
|
General Authorizing Resolution |
|
Management |
|
For |
|
For |
|
BIOCLIN THERAPEUTICS, INC.
Security |
N/A |
Meeting Type |
Written Consent |
Ticker Symbol |
N/A |
Meeting Date |
24-Apr-2018 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Amendment and Restatement of Restated Certificate of Incorporation |
|
Management |
|
For |
|
For |
|
2. |
|
Series B Preferred Stock Financing |
|
Management |
|
For |
|
For |
|
3. |
|
Waiver of Preemptive Rights |
|
Management |
|
For |
|
For |
|
4. |
|
Notice of Interested Party Transactions |
|
Management |
|
For |
|
For |
|
5. |
|
Amendment of 2013 Stock and Option Grant Plan |
|
Management |
|
For |
|
For |
|
6. |
|
General Authorizing Resolution |
|
Management |
|
For |
|
For |
|
BIOCLIN THERAPEUTICS, INC.
Security |
N/A |
Meeting Type |
Written Consent |
Ticker Symbol |
N/A |
Meeting Date |
21-May-2018 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Election of Director |
|
Management |
|
For |
|
For |
|
2. |
|
General Authorizing Resolution |
|
Management |
|
For |
|
For |
|
BIOGEN INC.
Security |
09062X103 |
Meeting Type |
Annual |
Ticker Symbol |
BIIB |
Meeting Date |
12-Jun-2018 |
Record Date |
17-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Alexander J. Denner |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Caroline D. Dorsa |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Nancy L. Leaming |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Richard C. Mulligan |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Robert W. Pangia |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Stelios Papadopoulos |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Brian S. Posner |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Eric K. Rowinsky |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Lynn Schenk |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Stephen A. Sherwin |
|
Management |
|
For |
|
For |
|
1k. |
|
Election of Director: Michel Vounatsos |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.s independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
Say on Pay - To approve an advisory vote on executive compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
Stockholder proposal requesting certain proxy access bylaw amendments. |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
Stockholder proposal requesting a report on the extent to which risks related to public concern over drug pricing strategies are integrated into incentive compensation arrangements. |
|
Shareholder |
|
Against |
|
For |
|
BOSTON SCIENTIFIC CORPORATION
Security |
101137107 |
Meeting Type |
Annual |
Ticker Symbol |
BSX |
Meeting Date |
10-May-2018 |
Record Date |
16-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Nelda J. Connors |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Charles J. Dockendorff |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Yoshiaki Fujimori |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Donna A. James |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Edward J. Ludwig |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Stephen P. MacMillan |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Michael F. Mahoney |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: David J. Roux |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: John E. Sununu |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Ellen M. Zane |
|
Management |
|
For |
|
For |
|
2. |
|
To approve, on a non-binding, advisory basis, named executive officer compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2018 fiscal year. |
|
Management |
|
For |
|
For |
|
BRISTOL-MYERS SQUIBB COMPANY
Security |
110122108 |
Meeting Type |
Annual |
Ticker Symbol |
BMY |
Meeting Date |
01-May-2018 |
Record Date |
14-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1A. |
|
Election of Director: P. J. Arduini |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director: J. Baselga, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director: R. J. Bertolini |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Director: G. Caforio, M.D. |
|
Management |
|
For |
|
For |
|
1E. |
|
Election of Director: M. W. Emmens |
|
Management |
|
For |
|
For |
|
1F. |
|
Election of Director: M. Grobstein |
|
Management |
|
For |
|
For |
|
1G. |
|
Election of Director: A. J. Lacy |
|
Management |
|
For |
|
For |
|
1H. |
|
Election of Director: D. C. Paliwal |
|
Management |
|
For |
|
For |
|
1I. |
|
Election of Director: T. R. Samuels |
|
Management |
|
For |
|
For |
|
1J. |
|
Election of Director: G. L. Storch |
|
Management |
|
For |
|
For |
|
1K. |
|
Election of Director: V. L. Sato, Ph.D. |
|
Management |
|
For |
|
For |
|
1L. |
|
Election of Director: K. H. Vousden, Ph.D. |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory vote to approve the compensation of our Named Executive Officers |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification of the appointment of an independent registered public accounting firm |
|
Management |
|
For |
|
For |
|
4. |
|
Shareholder Proposal on Annual Report Disclosing How Risks Related to Public Concern Over Drug Pricing Strategies are Incorporated into Incentive Compensation Plans |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
Shareholder Proposal to Lower the Share Ownership Threshold to Call Special Shareholder Meetings |
|
Shareholder |
|
Against |
|
For |
|
CARDINAL HEALTH, INC.
Security |
14149Y108 |
Meeting Type |
Annual |
Ticker Symbol |
CAH |
Meeting Date |
08-Nov-2017 |
Record Date |
11-Sep-2017 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1A. |
|
ELECTION OF DIRECTOR: DAVID J. ANDERSON |
|
Management |
|
For |
|
For |
|
1B. |
|
ELECTION OF DIRECTOR: COLLEEN F. ARNOLD |
|
Management |
|
For |
|
For |
|
1C. |
|
ELECTION OF DIRECTOR: GEORGE S. BARRETT |
|
Management |
|
For |
|
For |
|
1D. |
|
ELECTION OF DIRECTOR: CARRIE S. COX |
|
Management |
|
For |
|
For |
|
1E. |
|
ELECTION OF DIRECTOR: CALVIN DARDEN |
|
Management |
|
For |
|
For |
|
1F. |
|
ELECTION OF DIRECTOR: BRUCE L. DOWNEY |
|
Management |
|
For |
|
For |
|
1G. |
|
ELECTION OF DIRECTOR: PATRICIA A. HEMINGWAY HALL |
|
Management |
|
For |
|
For |
|
1H. |
|
ELECTION OF DIRECTOR: CLAYTON M. JONES |
|
Management |
|
For |
|
For |
|
1I. |
|
ELECTION OF DIRECTOR: GREGORY B. KENNY |
|
Management |
|
For |
|
For |
|
1J. |
|
ELECTION OF DIRECTOR: NANCY KILLEFER |
|
Management |
|
For |
|
For |
|
1K. |
|
ELECTION OF DIRECTOR: DAVID P. KING |
|
Management |
|
For |
|
For |
|
2. |
|
PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT AUDITOR FOR THE FISCAL YEAR ENDING JUNE 30, 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
PROPOSAL TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. |
|
Management |
|
For |
|
For |
|
4. |
|
PROPOSAL TO VOTE, ON A NON-BINDING ADVISORY BASIS, ON THE FREQUENCY OF FUTURE ADVISORY VOTES TO APPROVE EXECUTIVE COMPENSATION. |
|
Management |
|
1 Year |
|
For |
|
5. |
|
SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED, TO URGE THE BOARD OF DIRECTORS TO ADOPT A POLICY THAT THE CHAIRMAN OF THE BOARD BE AN INDEPENDENT DIRECTOR. |
|
Shareholder |
|
Against |
|
For |
|
6. |
|
SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED, TO REQUEST THAT THE BOARD OF DIRECTORS ADOPT A BYLAW PROVISION RESTRICTING MANAGEMENTS ACCESS TO VOTE TALLIES PRIOR TO THE ANNUAL MEETING WITH RESPECT TO CERTAIN EXECUTIVE PAY MATTERS. |
|
Shareholder |
|
Against |
|
For |
|
CELGENE CORPORATION
Security |
151020104 |
Meeting Type |
Annual |
Ticker Symbol |
CELG |
Meeting Date |
13-Jun-2018 |
Record Date |
19-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
Mark J. Alles |
|
|
|
For |
|
For |
|
|
|
2 |
R W Barker, D.Phil, OBE |
|
|
|
For |
|
For |
|
|
|
3 |
Hans E. Bishop |
|
|
|
For |
|
For |
|
|
|
4 |
Michael W. Bonney |
|
|
|
For |
|
For |
|
|
|
5 |
Michael D. Casey |
|
|
|
For |
|
For |
|
|
|
6 |
Carrie S. Cox |
|
|
|
For |
|
For |
|
|
|
7 |
Michael A. Friedman, MD |
|
|
|
For |
|
For |
|
|
|
8 |
Julia A. Haller, M.D. |
|
|
|
For |
|
For |
|
|
|
9 |
P. A. Hemingway Hall |
|
|
|
For |
|
For |
|
|
|
10 |
James J. Loughlin |
|
|
|
For |
|
For |
|
|
|
11 |
Ernest Mario, Ph.D. |
|
|
|
For |
|
For |
|
|
|
12 |
John H. Weiland |
|
|
|
For |
|
For |
|
2. |
|
Ratification of the appointment of KPMG LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
| |
3. |
|
Approval, by non-binding vote, of executive compensation of the Companys named executive officers. |
|
Management |
|
For |
|
For |
| |
4. |
|
Advisory vote on stockholder proposal to request the Companys Board of Directors to amend the Companys proxy access by-law provision to eliminate the limit on the number of stockholders that can aggregate their shares to achieve the holding requirement for nomination of directors, described in more detail in the proxy statement. |
|
Shareholder |
|
Against |
|
For |
| |
5. |
|
Advisory vote on stockholder proposal to request the Companys Board of Directors to adopt a policy and amend the Companys governing documents to require that the Chairman of the Board be an independent member, described in more detail in the proxy statement. |
|
Shareholder |
|
For |
|
Against |
|
CELLDEX THERAPEUTICS, INC.
Security |
15117B103 |
Meeting Type |
Annual |
Ticker Symbol |
CLDX |
Meeting Date |
13-Jun-2018 |
Record Date |
25-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
Larry Ellberger |
|
|
|
For |
|
For |
|
|
|
2 |
Anthony S. Marucci |
|
|
|
For |
|
For |
|
|
|
3 |
Keith L. Brownlie |
|
|
|
For |
|
For |
|
|
|
4 |
Herbert J. Conrad |
|
|
|
For |
|
For |
|
|
|
5 |
James J. Marino |
|
|
|
For |
|
For |
|
|
|
6 |
Gerald McMahon |
|
|
|
For |
|
For |
|
|
|
7 |
Harry H. Penner, Jr. |
|
|
|
For |
|
For |
|
|
|
8 |
Karen L. Shoos |
|
|
|
For |
|
For |
|
2. |
|
To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2018. |
|
Management |
|
For |
|
For |
| |
3. |
|
To approve an amendment to our Restated Certificate of Incorporation, as amended, and grant of discretionary authority to the Board of Directors to effect a reverse stock split. |
|
Management |
|
For |
|
For |
| |
4. |
|
To approve, on an advisory basis, the compensation of the Companys Named Executive Officers as disclosed in this proxy statement. |
|
Management |
|
For |
|
For |
|
CELLECTIS S.A.
Security |
15117K103 |
Meeting Type |
Annual |
Ticker Symbol |
CLLS |
Meeting Date |
26-Jun-2018 |
Record Date |
11-Jun-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Approval of the financial statements for the financial year ended December 31, 2017 |
|
Management |
|
For |
|
For |
|
2. |
|
Approval of the consolidated financial statements for the financial year ended December 31, 2017 |
|
Management |
|
For |
|
For |
|
3. |
|
Allocation of income for the financial year ended December 31, 2017 |
|
Management |
|
For |
|
For |
|
4. |
|
Approval of the agreements referred to in articles L. 225- 38 and the following sections of the French commercial code |
|
Management |
|
For |
|
For |
|
5. |
|
Setting the amount of the attendance fees to be granted to the non-executive directors |
|
Management |
|
For |
|
For |
|
6. |
|
Renewal of the term of office of director of Mr. Andre Choulika |
|
Management |
|
For |
|
For |
|
7. |
|
Renewal of the term of office of director of Mr. David Sourdive |
|
Management |
|
For |
|
For |
|
8. |
|
Renewal of the term of office of director of Mr. Alain-Paul Godard, independent director according to the rules of the U.S. Securities Exchange Act of 1934 (the Exchange Act) and Nasdaq Stock Market |
|
Management |
|
For |
|
For |
|
9. |
|
Renewal of the term of office of J.M.H. Conseil, as Companys Statutory Auditors |
|
Management |
|
For |
|
For |
|
10. |
|
Renewal of the term of office of Ernst & Young et Autres, as Companys Statutory Auditors |
|
Management |
|
For |
|
For |
|
11. |
|
Approval of 2017 Stock Option Plan and payment for the stock options or stock purchase plan adopted by the Board of Directors on October 11, 2017 |
|
Management |
|
For |
|
For |
|
12. |
|
Authorization to be given to the Board of Directors to buy back Company shares |
|
Management |
|
For |
|
For |
|
13. |
|
Authorization to be given to the Board of Directors for the purpose of reducing the share capital through the cancellation of shares in the context of the authorization to buy back its own shares |
|
Management |
|
For |
|
For |
|
14. |
|
Delegation of authority to be granted to the Board of Directors for the purpose of increasing the share capital by issuing ordinary shares and/or any securities, with a waiver of the preferential subscription rights of the shareholders, in favor of a category of persons meeting specified characteristics |
|
Management |
|
For |
|
For |
|
15. |
|
Delegation of authority to be granted to the Board of Directors for the purpose of increasing the share capital through the issuance of ordinary shares or of any securities with a waiver of the preferential subscription rights of the shareholders, in favor of a category of persons ensuring the underwriting of the Companys equity securities that may arise as part of an equity line financing or bond financing |
|
Management |
|
For |
|
For |
|
16. |
|
Delegation of authority to be granted to the Board of Directors for the purpose of increasing the share capital immediately or in the future by issuing ordinary shares or any securities, while maintaining the preferential subscription rights of shareholders |
|
Management |
|
For |
|
For |
|
17. |
|
Delegation of authority to be granted to the Board of Directors for the purpose of increasing the share capital through the issuance of ordinary shares and/or any securities, with waiver of the preferential subscription rights of the shareholders, through a public offering |
|
Management |
|
For |
|
For |
|
18. |
|
Delegation of authority to be granted to the Board of Directors for the purpose of increasing the share capital through the issuance of ordinary shares and/or of any securities, with waiver of the preferential subscription rights of the shareholders, through an offer to qualified investors or a restricted circle of investors within the meaning of paragraph II of article L. 411-2 of the French monetary and financial code |
|
Management |
|
For |
|
For |
|
19. |
|
Delegation granted to the Board of Directors to increase the number of securities to be issued in case of share capital increase with or without preferential subscription rights |
|
Management |
|
For |
|
For |
|
20. |
|
Overall limitations to the amount of issuances made under the 14th resolution, the 15th resolution, the 16th resolution, the 17th resolution, the 18th resolution, and the 19th resolution above |
|
Management |
|
For |
|
For |
|
21. |
|
Delegation of authority to be granted to the Board of Directors for the purpose of increasing the share capital by incorporation of premiums, reserves, profits or others |
|
Management |
|
For |
|
For |
|
22. |
|
Authorization to be given to the Board of Directors to grant options to subscribe or purchase Companys shares |
|
Management |
|
For |
|
For |
|
23. |
|
Authorization be given to the Board of Directors for the allocation of free shares existing and/or to be issued in the future |
|
Management |
|
For |
|
For |
|
24. |
|
Delegation of authority to be granted to the Board of Directors to issue warrants giving the right to subscribe ordinary shares of the Company - Cancellation of the preferential right of subscription to the benefit of a category of persons meeting specific characteristics |
|
Management |
|
For |
|
For |
|
25. |
|
Delegation of authority to be granted to the Board of Directors for the purpose of issuing warrants to subscribe to and/or acquire redeemable shares (BSAAR) or share subscription warrants - with a waiver of the preferential subscription rights in favor of the following category of beneficiaries: employees and corporate officers of the Company and its subsidiaries |
|
Management |
|
For |
|
For |
|
26. |
|
Authorization for the Board of Directors to freely allocate preferred shares of the Company to the employees and and/or the executive officers of the Company and its subsidiaries entailing the waiver by the shareholders of their preferential subscription rights |
|
Management |
|
For |
|
For |
|
27. |
|
Overall limitations to the amount of issues made under the 22nd resolution, the 23rd resolution, the 24th resolution, the 25th resolution and the 26th resolution above |
|
Management |
|
For |
|
For |
|
28. |
|
Removal of the obligation to submit certain decisions to the Board of Directors approval, as listed in Article 14.1.1. Section 4 of the bylaws |
|
Management |
|
For |
|
For |
|
29. |
|
Delegation to be granted to the Board of Directors for the purpose of an increase in the share capital whose subscription would be reserved to members of a company savings plan established pursuant to articles L. 3332-1 and following of the French labor code |
|
Management |
|
For |
|
N/A |
|
CENTENE CORPORATION
Security |
15135B101 |
Meeting Type |
Annual |
Ticker Symbol |
CNC |
Meeting Date |
24-Apr-2018 |
Record Date |
23-Feb-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1A. |
|
Election of Director: Jessica L. Blume |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director: Frederick H. Eppinger |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director: David L. Steward |
|
Management |
|
For |
|
For |
|
2. |
|
ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION. |
|
Management |
|
For |
|
For |
|
3. |
|
RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2018. |
|
Management |
|
For |
|
For |
|
CIGNA CORPORATION
Security |
125509109 |
Meeting Type |
Annual |
Ticker Symbol |
CI |
Meeting Date |
25-Apr-2018 |
Record Date |
26-Feb-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1A |
|
Election of Director: David M. Cordani |
|
Management |
|
For |
|
For |
|
1B |
|
Election of Director: Eric J. Foss |
|
Management |
|
For |
|
For |
|
1C |
|
Election of Director: Isaiah Harris, Jr. |
|
Management |
|
For |
|
For |
|
1D |
|
Election of Director: Roman Martinez IV |
|
Management |
|
For |
|
For |
|
1E |
|
Election of Director: John M. Partridge |
|
Management |
|
For |
|
For |
|
1F |
|
Election of Director: James E. Rogers |
|
Management |
|
For |
|
For |
|
1G |
|
Election of Director: Eric C. Wiseman |
|
Management |
|
For |
|
For |
|
1H |
|
Election of Director: Donna F. Zarcone |
|
Management |
|
For |
|
For |
|
1I |
|
Election of Director: William D. Zollars |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory approval of Cignas executive compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification of appointment of PricewaterhouseCoopers LLP as Cignas independent registered public accounting firm for 2018. |
|
Management |
|
For |
|
For |
|
4. |
|
Approval of an amendment to the Companys Restated Certificate of Incorporation to eliminate the supermajority voting requirement. |
|
Management |
|
For |
|
For |
|
COHERUS BIOSCIENCES INC
Security |
19249H103 |
Meeting Type |
Annual |
Ticker Symbol |
CHRS |
Meeting Date |
23-May-2018 |
Record Date |
02-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
Christos Richards |
|
|
|
For |
|
For |
|
|
|
2 |
V. Bryan Lawlis, Ph.D. |
|
|
|
For |
|
For |
|
2. |
|
To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
COMMUNITY HEALTH SYSTEMS, INC.
Security |
203668108 |
Meeting Type |
Annual |
Ticker Symbol |
CYH |
Meeting Date |
15-May-2018 |
Record Date |
19-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: John A. Clerico |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Michael Dinkins |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: James S. Ely III |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: John A. Fry |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Tim L. Hingtgen |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: William Norris Jennings, M.D. |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: K. Ranga Krishnan, MBBS |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Julia B. North |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Wayne T. Smith |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: H. James Williams, Ph.D. |
|
Management |
|
For |
|
For |
|
2. |
|
Proposal to approve on an advisory (non-binding) basis the compensation of the Companys named executive officers. |
|
Management |
|
For |
|
For |
|
3. |
|
Proposal to approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, which was approved by the Board of Directors as of March 14, 2018, subject to stockholder approval. |
|
Management |
|
For |
|
For |
|
4. |
|
Proposal to ratify the selection of Deloitte & Touche LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
5. |
|
Stockholder proposal entitled Clean Energy Resolution. |
|
Shareholder |
|
Against |
|
For |
|
CSL LTD
Security |
N/A |
Meeting Type |
Annual General Meeting |
Ticker Symbol |
CMXHF |
Meeting Date |
18-Oct-2017 |
Record Date |
16-Oct-2017 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
2.A |
|
TO RE-ELECT PROFESSOR JOHN SHINE AS A DIRECTOR |
|
Management |
|
For |
|
For |
|
2.B |
|
TO RE-ELECT MR BRUCE BROOK AS A DIRECTOR |
|
Management |
|
For |
|
For |
|
2.C |
|
TO RE-ELECT MS CHRISTINE OREILLY AS A DIRECTOR |
|
Management |
|
For |
|
For |
|
3 |
|
ADOPTION OF THE REMUNERATION REPORT |
|
Management |
|
For |
|
For |
|
4 |
|
GRANT OF PERFORMANCE SHARE UNITS TO THE CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR, MR PAUL PERREAULT |
|
Management |
|
For |
|
For |
|
CMMT |
|
IF YOU INTEND TO VOTE FOR THE REMUNERATION REPORT, THEN YOU SHOULD VOTE-AGAINST THE SPILL RESOLUTION |
|
Non-Voting |
|
N/A |
|
N/A |
|
5 |
|
SPILL RESOLUTION (CONTINGENT ITEM): THAT, SUBJECT TO AND CONDITIONAL ON AT LEAST 25% OF THE VOTES CAST ON THE RESOLUTION PROPOSED ON ITEM 3 (ADOPTION OF REMUNERATION REPORT) IN THIS NOTICE OF ANNUAL GENERAL MEETING BEING AGAINST THE ADOPTION OF THE REMUNERATION REPORT, AS REQUIRED BY THE CORPORATIONS ACT 2001 (CTH): (A) AN EXTRAORDINARY GENERAL MEETING OF THE COMPANY (SPILL MEETING) BE HELD WITHIN 90 DAYS AFTER THE PASSING OF THIS RESOLUTION; (B) ALL OF THE NON-EXECUTIVE DIRECTORS OF THE COMPANY IN OFFICE AT THE TIME WHEN THE RESOLUTION TO MAKE THE DIRECTORS REPORT FOR THE FINANCIAL YEAR ENDED 30 JUNE 2017 WAS PASSED, AND WHO REMAIN IN OFFICE AT THE TIME OF THE SPILL MEETING, CEASE TO HOLD OFFICE IMMEDIATELY BEFORE THE END OF THE SPILL MEETING; AND (C) RESOLUTIONS TO APPOINT PERSONS TO OFFICES THAT WILL BE VACATED IMMEDIATELY BEFORE THE END OF THE SPILL MEETING BE PUT TO THE VOTE AT THE SPILL MEETING |
|
Shareholder |
|
Against |
|
For |
|
CVS HEALTH CORPORATION
Security |
126650100 |
Meeting Type |
Special |
Ticker Symbol |
CVS |
Meeting Date |
13-Mar-2018 |
Record Date |
05-Feb-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Stock Issuance Proposal: To approve the issuance of shares of CVS Health Corporation common stock to shareholders of Aetna Inc. in the merger between Aetna Inc. and Hudson Merger Sub Corp., a wholly-owned subsidiary of CVS Health Corporation, pursuant to the terms and conditions of the Agreement and Plan of Merger dated as of December 3, 2017, as it may be amended from time to time, among CVS Health Corporation, Hudson Merger Sub Corp. and Aetna Inc. |
|
Management |
|
For |
|
For |
|
2. |
|
Adjournment Proposal: To approve the adjournment from time to time of the special meeting of stockholders of CVS Health Corporation if necessary to solicit additional proxies if there are not sufficient votes at the time of the special meeting, or any adjournment or postponement thereof, to approve the Stock Issuance Proposal. |
|
Management |
|
For |
|
For |
|
CVS HEALTH CORPORATION
Security |
126650100 |
Meeting Type |
Annual |
Ticker Symbol |
CVS |
Meeting Date |
04-Jun-2018 |
Record Date |
10-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Richard M. Bracken |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: C. David Brown II |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Alecia A. DeCoudreaux |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Nancy-Ann M. DeParle |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: David W. Dorman |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Anne M. Finucane |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Larry J. Merlo |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Jean-Pierre Millon |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Mary L. Schapiro |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Richard J. Swift |
|
Management |
|
For |
|
For |
|
1k. |
|
Election of Director: William C. Weldon |
|
Management |
|
For |
|
For |
|
1l. |
|
Election of Director: Tony L. White |
|
Management |
|
For |
|
For |
|
2. |
|
Proposal to ratify appointment of independent registered public accounting firm for 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
Say on Pay - an advisory vote on the approval of executive compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
Proposal to approve an amendment to the Companys Certificate of Incorporation to reduce the ownership threshold for our stockholders right to call special meetings. |
|
Management |
|
For |
|
For |
|
5. |
|
Stockholder proposal regarding executive pay confidential voting. |
|
Shareholder |
|
Against |
|
For |
|
DANAHER CORPORATION
Security |
235851102 |
Meeting Type |
Annual |
Ticker Symbol |
DHR |
Meeting Date |
08-May-2018 |
Record Date |
12-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1A. |
|
Election of Director: Donald J. Ehrlich |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director: Linda Hefner Filler |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director: Thomas P. Joyce, Jr. |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Director: Teri List-Stoll |
|
Management |
|
For |
|
For |
|
1E. |
|
Election of Director: Walter G. Lohr, Jr. |
|
Management |
|
For |
|
For |
|
1F. |
|
Election of Director: Mitchell P. Rales |
|
Management |
|
For |
|
For |
|
1G. |
|
Election of Director: Steven M. Rales |
|
Management |
|
For |
|
For |
|
1H. |
|
Election of Director: John T. Schwieters |
|
Management |
|
For |
|
For |
|
1I. |
|
Election of Director: Alan G. Spoon |
|
Management |
|
For |
|
For |
|
1J. |
|
Election of Director: Raymond C. Stevens, Ph.D. |
|
Management |
|
For |
|
For |
|
1K. |
|
Election of Director: Elias A. Zerhouni, M.D. |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the selection of Ernst & Young LLP as Danahers independent registered public accounting firm. |
|
Management |
|
For |
|
For |
|
3. |
|
To approve on an advisory basis the Companys named executive officer compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
To act upon a shareholder proposal requesting that Danaher reduce shareholder special meeting threshold from 25% to 10%. |
|
Shareholder |
|
Against |
|
For |
|
DIPLOMAT PHARMACY, INC.
Security |
25456K101 |
Meeting Type |
Annual |
Ticker Symbol |
DPLO |
Meeting Date |
12-Jun-2018 |
Record Date |
18-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
David Dreyer |
|
|
|
For |
|
For |
|
|
|
2 |
Philip R. Hagerman |
|
|
|
For |
|
For |
|
|
|
3 |
Shawn C. Tomasello |
|
|
|
For |
|
For |
|
2. |
|
Ratification of the appointment of BDO USA, LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
| |
3. |
|
Advisory approval of named executive officer compensation. |
|
Management |
|
For |
|
For |
|
DYNAVAX TECHNOLOGIES CORPORATION
Security |
268158201 |
Meeting Type |
Special |
Ticker Symbol |
DVAX |
Meeting Date |
31-Jul-2017 |
Record Date |
30-Jun-2017 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
TO APPROVE AN AMENDMENT TO THE COMPANYS SIXTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF COMMON STOCK FROM 69,500,000 TO 139,000,000. |
|
Management |
|
For |
|
For |
|
2. |
|
TO AUTHORIZE AN ADJOURNMENT OF THE MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF THE PROPOSAL 1. |
|
Management |
|
For |
|
For |
|
EDWARDS LIFESCIENCES CORPORATION
Security |
28176E108 |
Meeting Type |
Annual |
Ticker Symbol |
EW |
Meeting Date |
17-May-2018 |
Record Date |
22-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
ELECTION OF DIRECTOR: Michael A. Mussallem |
|
Management |
|
For |
|
For |
|
1b. |
|
ELECTION OF DIRECTOR: Kieran T. Gallahue |
|
Management |
|
For |
|
For |
|
1c. |
|
ELECTION OF DIRECTOR: Leslie S. Heisz |
|
Management |
|
For |
|
For |
|
1d. |
|
ELECTION OF DIRECTOR: William J. Link, Ph.D. |
|
Management |
|
For |
|
For |
|
1e. |
|
ELECTION OF DIRECTOR: Steven R. Loranger |
|
Management |
|
For |
|
For |
|
1f. |
|
ELECTION OF DIRECTOR: Martha H. Marsh |
|
Management |
|
For |
|
For |
|
1g. |
|
ELECTION OF DIRECTOR: Wesley W. von Schack |
|
Management |
|
For |
|
For |
|
1h. |
|
ELECTION OF DIRECTOR: Nicholas J. Valeriani |
|
Management |
|
For |
|
For |
|
2. |
|
ADVISORY VOTE TO APPROVE COMPENSATION OF NAMED EXECUTIVE OFFICERS |
|
Management |
|
For |
|
For |
|
3. |
|
RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM |
|
Management |
|
For |
|
For |
|
4. |
|
ADVISORY VOTE ON A STOCKHOLDER PROPOSAL REGARDING ACTION BY WRITTEN CONSENT |
|
Shareholder |
|
Against |
|
For |
|
ELI LILLY AND COMPANY
Security |
532457108 |
Meeting Type |
Annual |
Ticker Symbol |
LLY |
Meeting Date |
07-May-2018 |
Record Date |
12-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: K. Baicker |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: J. E. Fyrwald |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: J. Jackson |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: E. R. Marram |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: J. P. Tai |
|
Management |
|
For |
|
For |
|
2. |
|
Approval, by non-binding vote, of the compensation paid to the companys named executive officers. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification of Ernst & Young LLP as the principal independent auditor for 2018. |
|
Management |
|
For |
|
For |
|
4. |
|
Approve amendments to the Articles of Incorporation to eliminate the classified board structure. |
|
Management |
|
For |
|
For |
|
5. |
|
Approve amendments to the Articles of Incorporation to eliminate supermajority voting provisions. |
|
Management |
|
For |
|
For |
|
6. |
|
Approve the Amended and Restated 2002 Lilly Stock Plan. |
|
Management |
|
For |
|
For |
|
7. |
|
Shareholder proposal seeking support for the descheduling of cannabis. |
|
Shareholder |
|
Against |
|
For |
|
8. |
|
Shareholder proposal requesting report regarding direct and indirect political contributions. |
|
Shareholder |
|
Against |
|
For |
|
9. |
|
Shareholder proposal requesting report on policies and practices regarding contract animal laboratories. |
|
Shareholder |
|
Against |
|
For |
|
10. |
|
Shareholder proposal requesting report on extent to which risks related to public concern over drug pricing strategies are integrated into incentive compensation arrangements. |
|
Shareholder |
|
Against |
|
For |
|
ENDO INTERNATIONAL PLC
Security |
G30401106 |
Meeting Type |
Annual |
Ticker Symbol |
ENDP |
Meeting Date |
07-Jun-2018 |
Record Date |
13-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Roger H. Kimmel |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Paul V. Campanelli |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Shane M. Cooke |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Nancy J. Hutson, Ph.D. |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Michael Hyatt |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Sharad S. Mansukani, M.D. |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: William P. Montague |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Todd B. Sisitsky |
|
Management |
|
For |
|
For |
|
2. |
|
To approve the selection of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for the year ending December 31, 2018 and to authorize the Board of Directors, acting through the Audit Committee, to determine the independent registered public accounting firms remuneration. |
|
Management |
|
For |
|
For |
|
3. |
|
To approve, by advisory vote, named executive officer compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
To approve the Endo International plc Amended and Restated 2015 Stock Incentive Plan. |
|
Management |
|
For |
|
For |
|
5. |
|
To renew the Boards existing authority to issue shares under Irish law. |
|
Management |
|
For |
|
For |
|
6. |
|
To renew the Boards existing authority to opt-out of statutory pre-emption rights under Irish law. |
|
Management |
|
For |
|
For |
|
EXPRESS SCRIPTS HOLDING COMPANY
Security |
30219G108 |
Meeting Type |
Annual |
Ticker Symbol |
ESRX |
Meeting Date |
10-May-2018 |
Record Date |
13-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Maura C. Breen |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: William J. DeLaney |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Elder Granger, MD, MG, USA (Retired) |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Nicholas J. LaHowchic |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Thomas P. Mac Mahon |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Kathleen M. Mazzarella |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Frank Mergenthaler |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Woodrow A. Myers, Jr., MD |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Roderick A. Palmore |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: George Paz |
|
Management |
|
For |
|
For |
|
1k. |
|
Election of Director: William L. Roper, MD, MPH |
|
Management |
|
For |
|
For |
|
1l. |
|
Election of Director: Seymour Sternberg |
|
Management |
|
For |
|
For |
|
1m. |
|
Election of Director: Timothy Wentworth |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accountants for 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
To approve, by non-binding vote, the compensation of the Companys named executive officers. |
|
Management |
|
For |
|
For |
|
4. |
|
Stockholder proposal requesting the Company to report annually to the Board and stockholders identifying whether there exists a gender pay-gap among the Companys employees and other related disclosures. |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
Stockholder proposal requesting the Board annually review and publicly report on its cyber risk. |
|
Shareholder |
|
Against |
|
For |
|
FOAMIX PHARMACEUTICALS LTD
Security |
M46135105 |
Meeting Type |
Special |
Ticker Symbol |
FOMX |
Meeting Date |
27-Nov-2017 |
Record Date |
25-Oct-2017 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
(I) PAY MR. DOMZALSKI ANNUAL COMPENSATION OF $440,000 FOR HIS SERVICES AS THE CHIEF EXECUTIVE OFFICER OF THE COMPANY, EFFECTIVE AS OF JULY 1, 2017, (II) APPROVE MR. DOMZALSKIS CASH BONUS FOR THE SIX MONTH PERIOD COMMENCING AS OF JULY 1, 2017 UP TO A MAXIMUM AMOUNT OF $132,000, SUBJECT TO ...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL). |
|
Management |
|
For |
|
For |
|
1A. |
|
DO YOU HAVE A PERSONAL INTEREST IN THE APPROVAL OF THIS PROPOSAL #1? MARK FOR = YES OR AGAINST = NO. |
|
Management |
|
Against |
|
N/A |
|
2. |
|
AWARD MR. DOMZALSKI 327,720 OPTIONS AND 81,930 RSUS UNDER THE COMPANYS 2015 ISRAELI SHARE INCENTIVE PLAN AND ITS 2015 U.S. ADDENDUM. |
|
Management |
|
For |
|
For |
|
2A. |
|
DO YOU HAVE A PERSONAL INTEREST IN THE APPROVAL OF THIS PROPOSAL #2? MARK FOR = YES OR AGAINST = NO. |
|
Management |
|
Against |
|
N/A |
|
FOAMIX PHARMACEUTICALS LTD
Security |
M46135105 |
Meeting Type |
Annual |
Ticker Symbol |
FOMX |
Meeting Date |
08-May-2018 |
Record Date |
10-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1 |
|
Appoint Kesselman & Kesselman (a member firm of PricewaterhouseCoopers International Limited, or PwC) an independent registered public accounting firm, as the Companys independent public accountants for the fiscal year ending December 31, 2018, and authorize the Board (or the Audit Committee, if such authority is delegated to it by the Board) to fix the remuneration of such independent public accountants in accordance with the volume and nature of their services. |
|
Management |
|
For |
|
For |
|
2 |
|
Ratify the election of Mr. David Domzalski as a director of the Company. |
|
Management |
|
For |
|
For |
|
3 |
|
Approve the annual equity incentive awards to the Companys non- executive directors, as set out under Proposal 3 in the Companys proxy statement. |
|
Management |
|
For |
|
For |
|
4a |
|
Approve the equity incentive grants to Mr. Domzalski for 2017, as set out under Proposal 4(a) in the Companys proxy statement. |
|
Management |
|
For |
|
For |
|
4a1 |
|
Please confirm you are a controlling shareholder/have a personal interest in the approval of Proposal 4(a)? If you vote FOR=YES or not at all your vote may not count for the Corresponding Proposal For= Yes, No=Against |
|
Management |
|
Against |
|
N/A |
|
4b |
|
Approve the terms of Mr. Domzalskis cash bonus and equity compensation for 2018, as set out under Proposal 4(b) of the Companys proxy statement. |
|
Management |
|
For |
|
For |
|
4b1 |
|
Please confirm you are a controlling shareholder/have a personal interest in the approval of Proposal 4(b)? If you vote FOR=YES or not at all your vote may not count for the Corresponding Proposal For= Yes, No=Against |
|
Management |
|
Against |
|
N/A |
|
5a |
|
Approve the 2016 equity conversion bonus for Dr. Tamarkin in respect of 2016, as set out under Proposal 5(a) of the Companys proxy statement |
|
Management |
|
For |
|
For |
|
5a1 |
|
Please confirm you are a controlling shareholder/have a personal interest in the approval of Proposal 5(a)? If you vote FOR=YES or not at all your vote may not count for the Corresponding Proposal For= Yes, No=Against |
|
Management |
|
Against |
|
N/A |
|
5b |
|
Approve Dr. Tamarkins cash bonus in respect of the first half of 2017, as set out under Proposal 5(b) of the Companys proxy statement. |
|
Management |
|
For |
|
For |
|
5b1 |
|
Please confirm you are a controlling shareholder/have a personal interest in the approval of Proposal 5(b)? If you vote FOR=YES or not at all your vote may not count for the Corresponding Proposal For= Yes, No=Against |
|
Management |
|
Against |
|
N/A |
|
6. |
|
Approve the Companys Amended Compensation Policy, as set out under Proposal 6 of the Companys proxy statement. |
|
Management |
|
For |
|
For |
|
6a |
|
Please confirm you are a controlling shareholder/have a personal interest in the approval of Proposal 6? If you vote FOR=YES or not at all your vote may not count for the Corresponding Proposal For= Yes, No=Against |
|
Management |
|
Against |
|
N/A |
|
GENMAB A/S
Security |
K3967W102 |
Meeting Type |
Annual General Meeting |
Ticker Symbol |
GEN.CO |
Meeting Date |
10-Apr-2018 |
Record Date |
03-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1 |
|
REPORT OF THE BOARD OF DIRECTORS ON THE COMPANYS ACTIVITIES DURING THE YEAR |
|
Non-Voting |
|
N/A |
|
N/A |
|
2 |
|
APPROVAL OF THE AUDITED ANNUAL REPORT AND DISCHARGE OF THE BOARD OF DIRECTORS AND THE EXECUTIVE MANAGEMENT |
|
Management |
|
For |
|
For |
|
3 |
|
DECISION AS TO THE DISTRIBUTION OF PROFIT ACCORDING TO THE APPROVED ANNUAL REPORT |
|
Management |
|
For |
|
For |
|
4.A |
|
RE-ELECTION OF MEMBER OF THE BOARD OF DIRECTORS: MATS PETTERSSON |
|
Management |
|
For |
|
For |
|
4.B |
|
RE-ELECTION OF MEMBER OF THE BOARD OF DIRECTORS: DR. ANDERS GERSEL PEDERSEN |
|
Management |
|
For |
|
For |
|
4.C |
|
RE-ELECTION OF MEMBER OF THE BOARD OF DIRECTORS: DEIRDRE P. CONNELLY |
|
Management |
|
For |
|
For |
|
4.D |
|
RE-ELECTION OF MEMBER OF THE BOARD OF DIRECTORS: PERNILLE ERENBJERG |
|
Management |
|
For |
|
For |
|
4.E |
|
RE-ELECTION OF MEMBER OF THE BOARD OF DIRECTORS: ROLF HOFFMANN |
|
Management |
|
For |
|
For |
|
4.F |
|
RE-ELECTION OF MEMBER OF THE BOARD OF DIRECTORS: DR. PAOLO PAOLETTI |
|
Management |
|
For |
|
For |
|
5 |
|
RE-ELECTION OF PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB AS AUDITOR |
|
Management |
|
For |
|
For |
|
6.A |
|
PROPOSAL FROM THE BOARD OF DIRECTORS: AMENDMENT OF THE REMUNERATION PRINCIPLES FOR THE BOARD OF DIRECTORS AND THE EXECUTIVE MANAGEMENT |
|
Management |
|
For |
|
For |
|
6.B |
|
PROPOSAL FROM THE BOARD OF DIRECTORS: ADOPTION OF THE BOARD OF DIRECTORS REMUNERATION FOR 2018 |
|
Management |
|
For |
|
For |
|
6.C |
|
PROPOSAL FROM THE BOARD OF DIRECTORS: AMENDMENT OF ARTICLE 4A (AUTHORIZATION TO ISSUE SHARES) |
|
Management |
|
For |
|
For |
|
6.D |
|
PROPOSAL FROM THE BOARD OF DIRECTORS: AMENDMENT OF ARTICLE 8 (LANGUAGE OF DOCUMENTS PREPARED IN CONNECTION WITH THE GENERAL MEETING) |
|
Management |
|
For |
|
For |
|
6.E |
|
PROPOSAL FROM THE BOARD OF DIRECTORS: AMENDMENT OF ARTICLE 12 (RETIREMENT AGE FOR THE MEMBERS OF THE BOARD OF DIRECTORS) |
|
Management |
|
For |
|
For |
|
7 |
|
AUTHORIZATION OF CHAIRMAN OF GENERAL MEETING TO REGISTER RESOLUTIONS PASSED BY GENERAL MEETING |
|
Management |
|
For |
|
For |
|
8 |
|
MISCELLANEOUS |
|
Non-Voting |
|
N/A |
|
N/A |
|
GENOMEDX BIOSCIENCES, INC.
Security |
N/A |
Meeting Type |
Special |
Ticker Symbol |
N/A |
Meeting Date |
20-Nov-2017 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Authorized Share Structure Amendment Resolution |
|
Management |
|
For |
|
For |
|
2. |
|
Special Rights and Restrictions Resolution |
|
Management |
|
For |
|
For |
|
3. |
|
Class C Preferred Share Issuance Resolution |
|
Management |
|
For |
|
For |
|
GENOMEDX BIOSCIENCES, INC.
Security |
N/A |
Meeting Type |
Special |
Ticker Symbol |
N/A |
Meeting Date |
8-Jan-2018 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Non-shareholders as Proxyholders Resolution |
|
Management |
|
For |
|
For |
|
2. |
|
Special Rights and Restrictions Resolution |
|
Management |
|
For |
|
For |
|
GENOMEDX BIOSCIENCES, INC.
Security |
N/A |
Meeting Type |
Special |
Ticker Symbol |
N/A |
Meeting Date |
4-Feb-2018 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Non-shareholders as Proxyholders Resolution |
|
Management |
|
For |
|
For |
|
2. |
|
Authorized Share Structure Amendment Resolution |
|
Management |
|
For |
|
For |
|
3. |
|
Articles Amendment Resolution |
|
Management |
|
For |
|
For |
|
4. |
|
New Preferred Share Issuance Resolution |
|
Management |
|
For |
|
For |
|
GENOMEDX BIOSCIENCES, INC.
Security |
N/A |
Meeting Type |
Special |
Ticker Symbol |
N/A |
Meeting Date |
31-Mar-2018 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Non-shareholders as Proxyholders Resolution |
|
Management |
|
For |
|
For |
|
2. |
|
Authorized Share Structure Amendment Resolution |
|
Management |
|
For |
|
For |
|
3. |
|
Articles Amendment Resolution |
|
Management |
|
For |
|
For |
|
4. |
|
New Preferred Share Issuance Resolution |
|
Management |
|
For |
|
For |
|
GENOMEDX BIOSCIENCES, INC.
Security |
N/A |
Meeting Type |
Special |
Ticker Symbol |
N/A |
Meeting Date |
9-Jul-2018 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Non-shareholders as Proxyholders Resolution |
|
Management |
|
For |
|
For |
|
2. |
|
Domestication Resolution |
|
Management |
|
For |
|
For |
|
GILEAD SCIENCES, INC.
Security |
375558103 |
Meeting Type |
Annual |
Ticker Symbol |
GILD |
Meeting Date |
09-May-2018 |
Record Date |
16-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: John F. Cogan, Ph.D. |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Jacqueline K. Barton, Ph.D. |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Kelly A. Kramer |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Kevin E. Lofton |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: John C. Martin, Ph.D. |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: John F. Milligan, Ph.D. |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Richard J. Whitley, M.D. |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Gayle E. Wilson |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Per Wold-Olsen |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the selection of Ernst & Young LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. |
|
Management |
|
For |
|
For |
|
4. |
|
To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board adopt a policy that the Chairman of the Board of Directors be an independent director. |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board take steps to permit stockholder action by written consent. |
|
Shareholder |
|
Against |
|
For |
|
GLAXOSMITHKLINE PLC
Security |
37733W105 |
Meeting Type |
Annual |
Ticker Symbol |
GSK |
Meeting Date |
03-May-2018 |
Record Date |
23-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
To receive and adopt the 2017 Annual Report |
|
Management |
|
For |
|
For |
|
2. |
|
To approve the Annual report on remuneration |
|
Management |
|
For |
|
For |
|
3. |
|
To elect Dr Hal Barron as a Director |
|
Management |
|
For |
|
For |
|
4. |
|
To elect Dr Laurie Glimcher as a Director |
|
Management |
|
For |
|
For |
|
5. |
|
To re-elect Philip Hampton as a Director |
|
Management |
|
For |
|
For |
|
6. |
|
To re-elect Emma Walmsley as a Director |
|
Management |
|
For |
|
For |
|
7. |
|
To re-elect Vindi Banga as a Director |
|
Management |
|
For |
|
For |
|
8. |
|
To re-elect Dr Vivienne Cox as a Director |
|
Management |
|
For |
|
For |
|
9. |
|
To re-elect Simon Dingemans as a Director |
|
Management |
|
For |
|
For |
|
10. |
|
To re-elect Lynn Elsenhans as a Director |
|
Management |
|
For |
|
For |
|
11. |
|
To re-elect Dr Jesse Goodman as a Director |
|
Management |
|
For |
|
For |
|
12. |
|
To re-elect Judy Lewent as a Director |
|
Management |
|
For |
|
For |
|
13. |
|
To re-elect Urs Rohner as a Director |
|
Management |
|
For |
|
For |
|
14. |
|
To appoint auditors |
|
Management |
|
For |
|
For |
|
15. |
|
To determine remuneration of auditors |
|
Management |
|
For |
|
For |
|
16. |
|
To authorise the company and its subsidiaries to make donations to political organisations and incur political expenditure |
|
Management |
|
For |
|
For |
|
17. |
|
To authorise allotment of shares |
|
Management |
|
For |
|
For |
|
18. |
|
To disapply pre-emption rights - general power (special resolution) |
|
Management |
|
For |
|
For |
|
19. |
|
To disapply pre-emption rights - in connection with an acquisition or specified capital investment (special resolution) |
|
Management |
|
For |
|
For |
|
20. |
|
To authorise the company to purchase its own shares (special resolution) |
|
Management |
|
For |
|
For |
|
21. |
|
To authorise exemption from statement of name of senior statutory auditor |
|
Management |
|
For |
|
For |
|
22. |
|
To authorise reduced notice of a general meeting other than an AGM (special resolution) |
|
Management |
|
For |
|
For |
|
23. |
|
To approve adoption of new Articles of Association (special resolution) |
|
Management |
|
For |
|
For |
|
GLAXOSMITHKLINE PLC
Security |
37733W105 |
Meeting Type |
Special |
Ticker Symbol |
GSK |
Meeting Date |
03-May-2018 |
Record Date |
09-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
To approve the buyout of Novartis interest in GlaxoSmithKline Consumer Healthcare Holdings Limited for the purposes of Chapter 11 of the Listing Rules of the Financial Conduct Authority |
|
Management |
|
For |
|
For |
|
GLOBAL MEDICAL REIT INC.
Security |
37954A204 |
Meeting Type |
Annual |
Ticker Symbol |
GMRE |
Meeting Date |
30-May-2018 |
Record Date |
04-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
Jeffrey Busch |
|
|
|
For |
|
For |
|
|
|
2 |
Henry Cole |
|
|
|
For |
|
For |
|
|
|
3 |
Matthew L. Cypher, Ph.D |
|
|
|
For |
|
For |
|
|
|
4 |
Zhang Jingguo |
|
|
|
For |
|
For |
|
|
|
5 |
Ronald Marston |
|
|
|
For |
|
For |
|
|
|
6 |
Dr. Roscoe Moore |
|
|
|
For |
|
For |
|
|
|
7 |
Zhang Huiqi |
|
|
|
For |
|
For |
|
|
|
8 |
Lori Beth Wittman |
|
|
|
For |
|
For |
|
2. |
|
Advisory vote to approve the compensation of the Companys named executive officers. |
|
Management |
|
For |
|
For |
| |
3. |
|
Advisory vote on the frequency of the advisory vote on the compensation of the Companys named executive officers. |
|
Management |
|
1 Year |
|
For |
| |
4. |
|
To ratify the appointment of MaloneBailey, LLP as the Companys independent registered public accounting firm for the year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
HCA HEALTHCARE, INC.
Security |
40412C101 |
Meeting Type |
Annual |
Ticker Symbol |
HCA |
Meeting Date |
26-Apr-2018 |
Record Date |
07-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: R. Milton Johnson |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Robert J. Dennis |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Nancy-Ann DeParle |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Thomas F. Frist III |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: William R. Frist |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Charles O. Holliday, Jr. |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Ann H. Lamont |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Geoffrey G. Meyers |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Michael W. Michelson |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Wayne J. Riley, M.D. |
|
Management |
|
For |
|
For |
|
1k. |
|
Election of Director: John W. Rowe, M.D. |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2018 |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory vote to approve named executive officer compensation |
|
Management |
|
For |
|
For |
|
4. |
|
Advisory vote to approve the frequency of future advisory votes to approve named executive officer compensation |
|
Management |
|
1 Year |
|
For |
|
HCP, INC.
Security |
40414L109 |
Meeting Type |
Annual |
Ticker Symbol |
HCP |
Meeting Date |
26-Apr-2018 |
Record Date |
07-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Brian G. Cartwright |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Christine N. Garvey |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: David B. Henry |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Thomas M. Herzog |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Peter L. Rhein |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Joseph P. Sullivan |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification of the appointment of Deloitte & Touche LLP as HCPs independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
Approval, on an advisory basis, of executive compensation. |
|
Management |
|
For |
|
For |
|
HEALTHCARE REALTY TRUST INCORPORATED
Security |
421946104 |
Meeting Type |
Annual |
Ticker Symbol |
HR |
Meeting Date |
08-May-2018 |
Record Date |
09-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
David R. Emery |
|
|
|
For |
|
For |
|
|
|
2 |
Todd J. Meredith |
|
|
|
For |
|
For |
|
|
|
3 |
Nancy H. Agee |
|
|
|
For |
|
For |
|
|
|
4 |
Edward H. Braman |
|
|
|
For |
|
For |
|
|
|
5 |
Peter F. Lyle, Sr. |
|
|
|
For |
|
For |
|
|
|
6 |
Edwin B. Morris III |
|
|
|
For |
|
For |
|
|
|
7 |
John Knox Singleton |
|
|
|
For |
|
For |
|
|
|
8 |
Bruce D. Sullivan |
|
|
|
For |
|
For |
|
|
|
9 |
Christann M. Vasquez |
|
|
|
For |
|
For |
|
2. |
|
To ratify the appointment of BDO USA, LLP as the independent registered public accounting firm for the Company and its subsidiaries for the Companys 2018 fiscal year. |
|
Management |
|
For |
|
For |
| |
3. |
|
RESOLVED, that the shareholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Companys proxy statement for the 2018 Annual Meeting of Shareholders. |
|
Management |
|
For |
|
For |
|
HEALTHCARE TRUST OF AMERICA, INC.
Security |
42225P501 |
Meeting Type |
Annual |
Ticker Symbol |
HTA |
Meeting Date |
09-Jul-2018 |
Record Date |
20-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Scott D. Peters |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: W. Bradley Blair, II |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Vicki U. Booth |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Roberta B. Bowman |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Maurice J. DeWald |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Warren D. Fix |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Peter N. Foss |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Daniel S. Henson |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Larry L. Mathis |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Gary T. Wescombe |
|
Management |
|
For |
|
For |
|
2. |
|
To approve, on a non-binding advisory basis, the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
3. |
|
To consider and vote upon the ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
HIKMA PHARMACEUTICALS PLC
Security |
G4576K104 |
Meeting Type |
Annual General Meeting |
Ticker Symbol |
HIK |
Meeting Date |
18-May-2018 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1 |
|
TO RECEIVE THE ANNUAL REPORT AND ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2017 |
|
Management |
|
For |
|
For |
|
2 |
|
TO DECLARE A FINAL DIVIDEND OF 23 CENTS PER ORDINARY SHARE IN RESPECT OF THE YEAR ENDED 31 DECEMBER 2017 |
|
Management |
|
For |
|
For |
|
3 |
|
TO RE-APPOINT PRICEWATERHOUSECOOPERS LLP AS AUDITORS OF THE COMPANY |
|
Management |
|
For |
|
For |
|
4 |
|
TO AUTHORISE THE AUDIT COMMITTEE TO DETERMINE THE AUDITORS REMUNERATION |
|
Management |
|
For |
|
For |
|
5 |
|
TO ELECT SIGGI OLAFSSON AS A DIRECTOR OF THE COMPANY |
|
Management |
|
For |
|
For |
|
6 |
|
TO RE-ELECT SAID DARWAZAH AS A DIRECTOR OF THE COMPANY |
|
Management |
|
For |
|
For |
|
7 |
|
TO RE-ELECT MAZEN DARWAZAH AS A DIRECTOR OF THE COMPANY |
|
Management |
|
For |
|
For |
|
8 |
|
TO RE-ELECT ROBERT PICKERING AS A DIRECTOR OF THE COMPANY |
|
Management |
|
For |
|
For |
|
9 |
|
TO RE-ELECT ALI AL-HUSRY AS A DIRECTOR OF THE COMPANY |
|
Management |
|
For |
|
For |
|
10 |
|
TO RE-ELECT PATRICK BUTLER AS A DIRECTOR OF THE COMPANY |
|
Management |
|
For |
|
For |
|
11 |
|
TO RE-ELECT DR. JOCHEN GANN AS A DIRECTOR OF THE COMPANY |
|
Management |
|
For |
|
For |
|
12 |
|
TO RE-ELECT JOHN CASTELLANI AS A DIRECTOR OF THE COMPANY |
|
Management |
|
For |
|
For |
|
13 |
|
TO RE-ELECT DR. PAMELA KIRBY AS A DIRECTOR OF THE COMPANY |
|
Management |
|
For |
|
For |
|
14 |
|
TO RE-ELECT NINA HENDERSON AS A DIRECTOR OF THE COMPANY |
|
Management |
|
For |
|
For |
|
15 |
|
TO APPROVE THE REMUNERATION REPORT FOR THE YEAR ENDED 31 DECEMBER 2017 |
|
Management |
|
For |
|
For |
|
16 |
|
TO APPROVE AND ADOPT THE COMPANYS MANAGEMENT INCENTIVE PLAN |
|
Management |
|
For |
|
For |
|
17 |
|
AUTHORITY TO ALLOT SHARES UP TO AN AGGREGATE NOMINAL AMOUNT OF 8,022,630 GBP |
|
Management |
|
For |
|
For |
|
18 |
|
THAT SUBJECT TO THE PASSING ON RESOLUTION 17 ABOVE, THE DIRECTORS BE EMPOWERED TO ALLOT EQUITY SECURITIES FOR CASH ON A NON PRE-EMPTIVE BASIS |
|
Management |
|
For |
|
For |
|
19 |
|
THAT THE AUTHORITY UNDER RESOLUTION 18 BE FURTHER EXTENDED TO AN AGGREGATE NOMINAL AMOUNT OF 1,203,394 GBP |
|
Management |
|
For |
|
For |
|
20 |
|
AUTHORITY TO MAKE MARKET PURCHASES OF OWN SHARES UP TO 2,406,789 GBP REPRESENTING 10 PERCENT OF THE ISSUED SHARE CAPITAL OF THE COMPANY |
|
Management |
|
For |
|
For |
|
21 |
|
THAT A GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY OTHER THAN AN AGM, MAY BE CALLED ON 14 CLEAR DAYS NOTICE |
|
Management |
|
For |
|
For |
|
HORIZON PHARMA PLC
Security |
G4617B105 |
Meeting Type |
Annual |
Ticker Symbol |
HZNP |
Meeting Date |
03-May-2018 |
Record Date |
23-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1.a |
|
Election of Class I Director: William F. Daniel |
|
Management |
|
For |
|
For |
|
1.b |
|
Election of Class I Director: H. Thomas Watkins |
|
Management |
|
For |
|
For |
|
1.c |
|
Election of Class I Director: Pascale Witz |
|
Management |
|
For |
|
For |
|
2. |
|
Approval of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2018 and authorization of the Audit Committee to determine the auditors remuneration. |
|
Management |
|
For |
|
For |
|
3. |
|
Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the Proxy Statement. |
|
Management |
|
For |
|
For |
|
4. |
|
Indication, on an advisory basis, of the preferred frequency of shareholder advisory votes on the compensation of our named executive officers. |
|
Management |
|
1 Year |
|
For |
|
5. |
|
Authorization for us and/or any of our subsidiaries to make market purchases or overseas market purchases of our ordinary shares. |
|
Management |
|
For |
|
For |
|
6. |
|
Approval of our Amended and Restated 2014 Equity Incentive Plan. |
|
Management |
|
For |
|
For |
|
HUMANA INC.
Security |
444859102 |
Meeting Type |
Annual |
Ticker Symbol |
HUM |
Meeting Date |
19-Apr-2018 |
Record Date |
26-Feb-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Kurt J. Hilzinger |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Frank J. Bisignano |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Bruce D. Broussard |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Frank A. DAmelio |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Karen B. DeSalvo, M.D. |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: W. Roy Dunbar |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: David A. Jones, Jr. |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: William J. McDonald |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: William E. Mitchell |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: David B. Nash, M.D. |
|
Management |
|
For |
|
For |
|
1k. |
|
Election of Director: James J. OBrien |
|
Management |
|
For |
|
For |
|
1l. |
|
Election of Director: Marissa T. Peterson |
|
Management |
|
For |
|
For |
|
2. |
|
The ratification of the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm. |
|
Management |
|
For |
|
For |
|
3. |
|
The approval of the compensation of the named executive officers as disclosed in the 2018 proxy statement. |
|
Management |
|
For |
|
For |
|
IDEXX LABORATORIES, INC.
Security |
45168D104 |
Meeting Type |
Annual |
Ticker Symbol |
IDXX |
Meeting Date |
09-May-2018 |
Record Date |
16-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Bruce L. Claflin |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Daniel M. Junius |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for the current fiscal year. |
|
Management |
|
For |
|
For |
|
3. |
|
Approval of the Adoption of the IDEXX Laboratories, Inc. 2018 Incentive Plan. To approve the Companys 2018 Stock Incentive Plan. |
|
Management |
|
For |
|
For |
|
4. |
|
Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Companys executive compensation. |
|
Management |
|
For |
|
For |
|
ILLUMINOSS MEDICAL, INC.
Security |
N/A |
Meeting Type |
Written Consent |
Ticker Symbol |
N/A |
Meeting Date |
14-Nov-2017 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Sixth Amended and Restated Certificate of Incorporation |
|
Management |
|
For |
|
For |
|
2. |
|
Convertible Note Financing |
|
Management |
|
For |
|
For |
|
3. |
|
Amendment of March 2017 Notes and Warrants |
|
Management |
|
For |
|
For |
|
4. |
|
Anti-Dilution |
|
Management |
|
For |
|
For |
|
5. |
|
General Resolutions |
|
Management |
|
For |
|
For |
|
INCYTE CORPORATION
Security |
45337C102 |
Meeting Type |
Annual |
Ticker Symbol |
INCY |
Meeting Date |
01-May-2018 |
Record Date |
05-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1.1 |
|
Election of Director: Julian C. Baker |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election of Director: Jean-Jacques Bienaime |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election of Director: Paul A. Brooke |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election of Director: Paul J. Clancy |
|
Management |
|
For |
|
For |
|
1.5 |
|
Election of Director: Wendy L. Dixon |
|
Management |
|
For |
|
For |
|
1.6 |
|
Election of Director: Jacqualyn A. Fouse |
|
Management |
|
For |
|
For |
|
1.7 |
|
Election of Director: Paul A. Friedman |
|
Management |
|
For |
|
For |
|
1.8 |
|
Election of Director: Herve Hoppenot |
|
Management |
|
For |
|
For |
|
2. |
|
To approve, on a non-binding, advisory basis, the compensation of the Companys named executive officers. |
|
Management |
|
For |
|
For |
|
3. |
|
To approve amendments to the Companys Amended and Restated 2010 Stock Incentive Plan. |
|
Management |
|
For |
|
For |
|
4. |
|
To ratify the appointment of Ernst & Young LLP as the Companys independent registered public accounting firm for 2018. |
|
Management |
|
For |
|
For |
|
INNATE PHARMA S.A.
Security |
F5277D100 |
Meeting Type |
MIX |
Ticker Symbol |
IPH |
Meeting Date |
29-May-2018 |
Record Date |
24-May-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
O.1 |
|
APPROVAL OF THE CORPORATE FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR 2017 |
|
Management |
|
For |
|
For |
|
O.2 |
|
APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR 2017 |
|
Management |
|
For |
|
For |
|
O.3 |
|
ALLOCATION OF INCOME FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2017 |
|
Management |
|
For |
|
For |
|
O.4 |
|
REGULATED AGREEMENTS AND COMMITMENTS |
|
Management |
|
For |
|
For |
|
O.5 |
|
RENEWAL OF THE TERM OF OFFICE OF AUDIT CONSEIL EXPERTISE, SA AS PRINCIPLE STATUTORY AUDITOR |
|
Management |
|
For |
|
For |
|
O.6 |
|
RATIFICATION OF THE CO-OPTATION OF MR. JEAN- YVES BLAY AS MEMBER OF THE SUPERVISORY BOARD, AS A REPLACEMENT FOR MR. JEAN- CHARLES SONIA |
|
Management |
|
For |
|
For |
|
O.7 |
|
RENEWAL OF THE TERM OF OFFICE OF MR. OLIVIER MARTINEZ AS CENSOR OF THE SUPERVISORY BOARD |
|
Management |
|
For |
|
For |
|
O.8 |
|
SETTING OF THE ATTENDANCE FEES TO BE ALLOCATED TO MEMBERS OF THE SUPERVISORY BOARD |
|
Management |
|
For |
|
For |
|
O.9 |
|
APPROVAL OF THE PRINCIPLES AND CRITERIA FOR DETERMINING, DISTRIBUTING AND ALLOCATING THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND ATTRIBUTABLE TO THE CHAIRMAN OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2018 |
|
Management |
|
For |
|
For |
|
O.10 |
|
APPROVAL OF THE PRINCIPLES AND CRITERIA FOR DETERMINING, DISTRIBUTING AND ALLOCATING THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND ATTRIBUTABLE TO MEMBERS OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2018 |
|
Management |
|
For |
|
For |
|
O.11 |
|
APPROVAL OF THE PRINCIPLES AND CRITERIA FOR DETERMINING, DISTRIBUTING AND ALLOCATING THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND ATTRIBUTABLE TO THE CHAIRMAN OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2018 |
|
Management |
|
For |
|
For |
|
O.12 |
|
APPROVAL OF THE PRINCIPLES AND CRITERIA FOR DETERMINING, DISTRIBUTING AND ALLOCATING THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND ATTRIBUTABLE TO MEMBERS OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2018 |
|
Management |
|
For |
|
For |
|
O.13 |
|
APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND PAID OR DUE TO THE CHAIRMAN OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2017 |
|
Management |
|
For |
|
For |
|
O.14 |
|
APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND PAID OR DUE TO MR. YANNIS MOREL AS MEMBER OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2017 |
|
Management |
|
For |
|
For |
|
O.15 |
|
APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND PAID OR DUE TO THE CHAIRMAN OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2017 |
|
Management |
|
For |
|
For |
|
O.16 |
|
AUTHORISATION FOR THE COMPANY TO PURCHASE ITS OWN SHARES |
|
Management |
|
For |
|
For |
|
E.17 |
|
AUTHORISATION GRANTED TO THE MANAGEMENT BOARD TO ALLOCATE FREE EXISTING SHARES OR FREE SHARES TO BE ISSUED TO EMPLOYEE MEMBERS OF THE EXECUTIVE COMMITTEE, EMPLOYEE SENIOR OFFICERS AND/OR CORPORATE OFFICERS OF THE COMPANY OR ITS SUBSIDIARIES AS PART OF THEIR ANNUAL VARIABLE COMPENSATION |
|
Management |
|
For |
|
For |
|
E.18 |
|
AUTHORISATION GRANTED TO THE MANAGEMENT BOARD TO ALLOCATE FREE EXISTING SHARES OR FREE SHARES TO BE ISSUED FOR THE BENEFIT OF EMPLOYEES OF THE COMPANY OR ITS SUBSIDIARIES |
|
Management |
|
For |
|
For |
|
E.19 |
|
AUTHORISATION GRANTED TO THE MANAGEMENT BOARD TO ALLOCATE FREE EXISTING SHARES OR FREE SHARES TO BE ISSUED BASED ON THE ACHIEVEMENT OF PERFORMANCE CRITERIA FOR THE BENEFIT OF SALARIED EXECUTIVE OFFICERS, EMPLOYEE MEMBERS OF THE EXECUTIVE COMMITTEE, EMPLOYEE SENIOR OFFICERS AND/OR CORPORATE OFFICERS OF THE COMPANY OR ITS SUBSIDIARIES |
|
Management |
|
For |
|
For |
|
E.20 |
|
AUTHORISATION GRANTED TO THE MANAGEMENT BOARD TO ALLOT FREE EXISTING SHARES OR FREE SHARES TO BE ISSUED BASED ON THE ACHIEVEMENT OF PERFORMANCE CRITERIA FOR THE BENEFIT OF EMPLOYEES OF THE COMPANY OR ITS SUBSIDIARIES |
|
Management |
|
For |
|
For |
|
E.21 |
|
DELEGATION OF AUTHORITY TO THE MANAGEMENT BOARD TO ISSUE INDIVIDUAL SHARE SUBSCRIPTION WARRANTS RESERVED FOR MEMBERS OF THE SUPERVISORY BOARD |
|
Management |
|
For |
|
For |
|
E.22 |
|
DELEGATION OF AUTHORITY TO THE MANAGEMENT BOARD TO ISSUE COMMON SHARES OF THE COMPANY AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE COMPANYS CAPITAL, WITH RETENTION OF THE SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION RIGHT |
|
Management |
|
For |
|
For |
|
E.23 |
|
DELEGATION OF AUTHORITY TO THE MANAGEMENT BOARD TO ISSUE COMMON SHARES OF THE COMPANY AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE COMPANYS CAPITAL, WITH CANCELLATION OF THE SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION RIGHT |
|
Management |
|
For |
|
For |
|
E.24 |
|
DELEGATION OF AUTHORITY TO THE MANAGEMENT BOARD TO ISSUE COMMON SHARES OF THE COMPANY AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE COMPANYS CAPITAL, WITH CANCELLATION OF THE SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION RIGHT, IN THE CONTEXT OF AN OFFER REFERRED TO IN SECTION II OF ARTICLE L. 411-2 OF THE FRENCH MONETARY AND FINANCIAL CODE |
|
Management |
|
For |
|
For |
|
E.25 |
|
SETTING OF THE ISSUE PRICE OF COMMON SHARES AND/OR ANY TRANSFERABLE SECURITIES GRANTING ACCESS TO THE CAPITAL, IN CASE OF CANCELLATION OF THE PRE-EMPTIVE SUBSCRIPTION RIGHT, WITHIN THE ANNUAL LIMIT OF 10% OF THE CAPITAL |
|
Management |
|
For |
|
For |
|
E.26 |
|
DELEGATION OF AUTHORITY TO THE MANAGEMENT BOARD TO ISSUE COMMON SHARES OF THE COMPANY AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE COMPANYS CAPITAL, WITH CANCELLATION OF THE SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION RIGHT AND IN FAVOUR OF CATEGORIES OF PERSONS |
|
Management |
|
For |
|
For |
|
E.27 |
|
AUTHORISATION GRANTED TO THE MANAGEMENT BOARD IN THE EVENT OF AN INCREASE OF THE CAPITAL, WITH OR WITHOUT CANCELLATION OF THE SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION RIGHT, TO INCREASE THE NUMBER OF SECURITIES TO BE ISSUED BY 15% |
|
Management |
|
For |
|
For |
|
E.28 |
|
DELEGATION OF POWERS TO THE MANAGEMENT BOARD TO ISSUE COMMON SHARES AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE COMPANYS CAPITAL, AS CONSIDERATION FOR CONTRIBUTIONS IN KIND CONSISTING OF EQUITY SECURITIES OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE CAPITAL |
|
Management |
|
For |
|
For |
|
E.29 |
|
DELEGATION OF AUTHORITY TO THE MANAGEMENT BOARD TO ISSUE COMMON SHARES AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE COMPANYS CAPITAL, IN THE EVENT OF A PUBLIC EXCHANGE OFFER INITIATED BY THE COMPANY |
|
Management |
|
For |
|
For |
|
E.30 |
|
OVERALL LIMITATION OF THE AUTHORIZATIONS UNDER RESOLUTIONS N DECREE 22 TO 24 AND 26 TO 29 ABOVE |
|
Management |
|
For |
|
For |
|
E.31 |
|
DELEGATION OF AUTHORITY TO THE MANAGEMENT BOARD TO ISSUE COMMON SHARES AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE CAPITAL OF THE COMPANY FOR THE BENEFIT OF MEMBERS OF A COMPANY SAVINGS PLAN |
|
Management |
|
For |
|
For |
|
E.32 |
|
DELEGATION OF AUTHORITY GRANTED TO THE MANAGEMENT BOARD TO CANCEL ALL OR PART OF THE SHARES HELD BY THE COMPANY, AS PART OF THE AUTHORIZATION TO BUY BACK SHARES |
|
Management |
|
For |
|
For |
|
E.33 |
|
AMENDMENT TO ARTICLE 12 OF THE BYLAWS OF THE COMPANY IN ORDER TO INTRODUCE A DOUBLE VOTING RIGHT ATTACHED TO COMMON SHARES |
|
Management |
|
For |
|
For |
|
E.34 |
|
AMENDMENT TO ARTICLE 25 OF THE BYLAWS OF THE COMPANY TO MAKE THE APPOINTMENT OF ONE OR MORE DEPUTY STATUTORY AUDITORS NO LONGER MANDATORY |
|
Management |
|
For |
|
For |
|
E.35 |
|
POWERS TO CARRY OUT ALL LEGAL FORMALITIES |
|
Management |
|
For |
|
For |
|
INTUITIVE SURGICAL, INC.
Security |
46120E602 |
Meeting Type |
Annual |
Ticker Symbol |
ISRG |
Meeting Date |
19-Apr-2018 |
Record Date |
23-Feb-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1A. |
|
Election of Director: Craig H. Barratt, Ph.D. |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director: Michael A. Friedman, M.D. |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director: Gary S. Guthart, Ph.D. |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Director: Amal M. Johnson |
|
Management |
|
For |
|
For |
|
1E. |
|
Election of Director: Keith R. Leonard, Jr. |
|
Management |
|
For |
|
For |
|
1F. |
|
Election of Director: Alan J. Levy, Ph.D. |
|
Management |
|
For |
|
For |
|
1G. |
|
Election of Director: Jami Dover Nachtsheim |
|
Management |
|
For |
|
For |
|
1H. |
|
Election of Director: Mark J. Rubash |
|
Management |
|
For |
|
For |
|
1I. |
|
Election of Director: Lonnie M. Smith |
|
Management |
|
For |
|
For |
|
2. |
|
To approve, by advisory vote, the compensation of the Companys Named Executive Officers. |
|
Management |
|
For |
|
For |
|
3. |
|
The ratification of appointment of PricewaterhouseCoopers LLP (PwC) as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
JOHNSON & JOHNSON
Security |
478160104 |
Meeting Type |
Annual |
Ticker Symbol |
JNJ |
Meeting Date |
26-Apr-2018 |
Record Date |
27-Feb-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Mary C. Beckerle |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: D. Scott Davis |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Ian E. L. Davis |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Jennifer A. Doudna |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Alex Gorsky |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Mark B. McClellan |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Anne M. Mulcahy |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: William D. Perez |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Charles Prince |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: A. Eugene Washington |
|
Management |
|
For |
|
For |
|
1k. |
|
Election of Director: Ronald A. Williams |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory Vote to Approve Named Executive Officer Compensation |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2018 |
|
Management |
|
For |
|
For |
|
4. |
|
Shareholder Proposal - Accounting for Litigation and Compliance in Executive Compensation Performance Measures |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
Shareholder Proposal - Amendment to Shareholder Ability to Call Special Shareholder Meeting |
|
Shareholder |
|
Against |
|
For |
|
KONINKLIJKE PHILIPS ELECTRONICS N.V.
Security |
500472303 |
Meeting Type |
Annual |
Ticker Symbol |
PHG |
Meeting Date |
03-May-2018 |
Record Date |
26-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
2d. |
|
Proposal to adopt the financial statements |
|
Management |
|
For |
|
For |
|
2e. |
|
Proposal to adopt dividend |
|
Management |
|
For |
|
For |
|
2f. |
|
Proposal to discharge the members of the Board of Management |
|
Management |
|
For |
|
For |
|
2g. |
|
Proposal to discharge the members of the Supervisory Board |
|
Management |
|
For |
|
For |
|
3a. |
|
Proposal to re-appoint Ms O. Gadiesh as member of the Supervisory Board |
|
Management |
|
For |
|
For |
|
3b. |
|
Proposal to appoint Mr P.A. Stoffels as member of the Supervisory Board |
|
Management |
|
For |
|
For |
|
4a. |
|
Proposal to authorize the Board of Management to issue shares or grant rights to acquire shares. |
|
Management |
|
For |
|
For |
|
4b. |
|
Proposal to authorize the Board of Management to restrict or exclude pre-emption rights |
|
Management |
|
For |
|
For |
|
5. |
|
Proposal to authorize the Board of Management to acquire shares in the company |
|
Management |
|
For |
|
For |
|
6. |
|
Proposal to cancel shares |
|
Management |
|
For |
|
For |
|
LIVANOVA PLC
Security |
G5509L101 |
Meeting Type |
Annual |
Ticker Symbol |
LIVN |
Meeting Date |
12-Jun-2018 |
Record Date |
19-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Mr. Francesco Bianchi |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Mr. William A. Kozy |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Mr. Damien McDonald |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Mr. Daniel J. Moore |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Mr. Hugh M. Morrison |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Mr. Alfred J. Novak |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Dr. Sharon OKane |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Dr. Arthur L. Rosenthal |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Ms. Andrea L. Saia |
|
Management |
|
For |
|
For |
|
2. |
|
To approve, on an advisory basis, the frequency of U.S. Say-on-Pay votes (U.S. Say-on-Frequency). |
|
Management |
|
1 Year |
|
For |
|
3. |
|
To approve, on an advisory basis, LivaNovas compensation of its named executive officers (U.S. Say- on-Pay). |
|
Management |
|
For |
|
For |
|
4. |
|
To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership (PwC USA) as the Companys independent registered public accountancy firm for the year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
5. |
|
To approve, on an advisory basis, the U.K. directors remuneration report in the form set out in the Companys U.K. annual report and accounts (U.K. Annual Report) for the period ended December 31, 2017. |
|
Management |
|
For |
|
For |
|
6. |
|
To approve the LivaNova Global Employee Share Purchase Plan. |
|
Management |
|
For |
|
For |
|
7. |
|
To receive and adopt the Companys audited U.K. statutory accounts for the year ended December 31, 2017, together with the reports of the directors and the auditors thereon. |
|
Management |
|
For |
|
For |
|
8. |
|
To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England (PwC U.K.), as the Companys U.K. statutory auditor under the U.K. Companies Act 2006 to hold office from the conclusion of the Annual General Meeting until the conclusion of the next general meeting at which the annual report and accounts are laid. |
|
Management |
|
For |
|
For |
|
9. |
|
To authorize the directors and/or the Audit and Compliance Committee of the Company to determine the remuneration of PwC U.K. in its capacity as the Companys U.K. statutory auditor under the U.K. Companies Act 2006. |
|
Management |
|
For |
|
For |
|
LTC PROPERTIES, INC.
Security |
502175102 |
Meeting Type |
Annual |
Ticker Symbol |
LTC |
Meeting Date |
30-May-2018 |
Record Date |
16-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1.1 |
|
Election of Director: Boyd W. Hendrickson |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election of Director: James J. Pieczynski |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election of Director: Devra G. Shapiro |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election of Director: Wendy L. Simpson |
|
Management |
|
For |
|
For |
|
1.5 |
|
Election of Director: Timothy J. Triche, M.D. |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification of independent registered public accounting firm. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory vote to approve named executive officer compensation. |
|
Management |
|
For |
|
For |
|
MALLINCKRODT PLC
Security |
G5785G107 |
Meeting Type |
Annual |
Ticker Symbol |
MNK |
Meeting Date |
16-May-2018 |
Record Date |
12-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: David R. Carlucci |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: J. Martin Carroll |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Paul R. Carter |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: David Y. Norton |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: JoAnn A. Reed |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Angus C. Russell |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Mark C. Trudeau |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Anne C. Whitaker |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Kneeland C. Youngblood, M.D. |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Joseph A. Zaccagnino |
|
Management |
|
For |
|
For |
|
2. |
|
Approve, in a non-binding vote, the re-appointment of the Independent Auditors and to authorize, in a binding vote, the Audit Committee to set the auditors remuneration. |
|
Management |
|
For |
|
For |
|
3. |
|
Approve, in a non-binding advisory vote, the compensation of named executive officers. |
|
Management |
|
Against |
|
Against |
|
4. |
|
Approve the Amended and Restated Mallinckrodt Pharmaceuticals Stock and Incentive Plan. |
|
Management |
|
Against |
|
Against |
|
5. |
|
Approve the authority of the Board to issue shares. |
|
Management |
|
For |
|
For |
|
6. |
|
Approve the waiver of pre-emption rights (Special Resolution). |
|
Management |
|
For |
|
For |
|
7. |
|
Authorize the Company and/or any subsidiary to make market purchases or overseas market purchases of Company shares. |
|
Management |
|
For |
|
For |
|
8. |
|
Authorize the price range at which the Company can re- allot shares it holds as treasury shares (Special Resolution) |
|
Management |
|
For |
|
For |
|
MASIMO CORPORATION
Security |
574795100 |
Meeting Type |
Annual |
Ticker Symbol |
MASI |
Meeting Date |
31-May-2018 |
Record Date |
02-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1.1 |
|
Election of Class II Director: Joe Kiani |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election of Class II Director: Thomas Harkin |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the selection of Grant Thornton LLP as the Companys independent registered public accounting firm for fiscal year ending December 29, 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory vote to approve named executive officer compensation. |
|
Management |
|
For |
|
For |
|
MCKESSON CORPORATION
Security |
58155Q103 |
Meeting Type |
Annual |
Ticker Symbol |
MCK |
Meeting Date |
25-Jul-2018 |
Record Date |
31-May-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: N. Anthony Coles, M.D. |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: John H. Hammergren |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: M. Christine Jacobs |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Donald R. Knauss |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Marie L. Knowles |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Bradley E. Lerman |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Edward A. Mueller |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Susan R. Salka |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification of the appointment of Deloitte & Touche LLP as the companys independent registered public accounting firm for the fiscal year ending March 31, 2019. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory vote on executive compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
Shareholder proposal on disclosure of lobbying activities and expenditures. |
|
Shareholder |
|
Against |
|
For |
|
5. |
|
Shareholder proposal on accelerated vesting of equity awards. |
|
Shareholder |
|
Against |
|
For |
|
6. |
|
Shareholder proposal on policy to use GAAP financial metrics for purposes of determining executive compensation. |
|
Shareholder |
|
Against |
|
For |
|
7. |
|
Shareholder proposal on the ownership threshold for calling special meetings of shareholders. |
|
Shareholder |
|
Against |
|
For |
|
MEDICAL PROPERTIES TRUST, INC.
Security |
58463J304 |
Meeting Type |
Annual |
Ticker Symbol |
MPW |
Meeting Date |
24-May-2018 |
Record Date |
20-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1.1 |
|
Election of Director: Edward K. Aldag, Jr. |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election of Director: G. Steven Dawson |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election of Director: R. Steven Hamner |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election of Director: Elizabeth N. Pitman |
|
Management |
|
For |
|
For |
|
1.5 |
|
Election of Director: C. Reynolds Thompson, III |
|
Management |
|
For |
|
For |
|
1.6 |
|
Election of Director: D. Paul Sparks, Jr. |
|
Management |
|
For |
|
For |
|
1.7 |
|
Election of Director: Michael G. Stewart |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory approval of the Companys executive compensation. |
|
Management |
|
For |
|
For |
|
MEDTRONIC PLC
Security |
G5960L103 |
Meeting Type |
Annual |
Ticker Symbol |
MDT |
Meeting Date |
08-Dec-2017 |
Record Date |
10-Oct-2017 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1A. |
|
ELECTION OF DIRECTOR: RICHARD H. ANDERSON |
|
Management |
|
For |
|
For |
|
1B. |
|
ELECTION OF DIRECTOR: CRAIG ARNOLD |
|
Management |
|
For |
|
For |
|
1C. |
|
ELECTION OF DIRECTOR: SCOTT C. DONNELLY |
|
Management |
|
For |
|
For |
|
1D. |
|
ELECTION OF DIRECTOR: RANDALL HOGAN III |
|
Management |
|
For |
|
For |
|
1E. |
|
ELECTION OF DIRECTOR: OMAR ISHRAK |
|
Management |
|
For |
|
For |
|
1F. |
|
ELECTION OF DIRECTOR: SHIRLEY A. JACKSON, PH.D. |
|
Management |
|
For |
|
For |
|
1G. |
|
ELECTION OF DIRECTOR: MICHAEL O. LEAVITT |
|
Management |
|
For |
|
For |
|
1H. |
|
ELECTION OF DIRECTOR: JAMES T. LENEHAN |
|
Management |
|
For |
|
For |
|
1I. |
|
ELECTION OF DIRECTOR: ELIZABETH NABEL, M.D. |
|
Management |
|
For |
|
For |
|
1J. |
|
ELECTION OF DIRECTOR: DENISE M. OLEARY |
|
Management |
|
For |
|
For |
|
1K. |
|
ELECTION OF DIRECTOR: KENDALL J. POWELL |
|
Management |
|
For |
|
For |
|
1L. |
|
ELECTION OF DIRECTOR: ROBERT C. POZEN |
|
Management |
|
For |
|
For |
|
2. |
|
TO RATIFY, IN A NON-BINDING VOTE, THE RE- APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS MEDTRONICS INDEPENDENT AUDITOR FOR FISCAL YEAR 2018 AND AUTHORIZE THE BOARD OF DIRECTORS, ACTING THROUGH THE AUDIT COMMITTEE, TO SET THE AUDITORS REMUNERATION. |
|
Management |
|
For |
|
For |
|
3. |
|
TO APPROVE IN A NON-BINDING ADVISORY VOTE, NAMED EXECUTIVE OFFICER COMPENSATION (A SAY-ON-PAY VOTE). |
|
Management |
|
For |
|
For |
|
4. |
|
TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE MEDTRONIC PLC AMENDED AND RESTATED 2013 STOCK AWARD AND INCENTIVE PLAN. |
|
Management |
|
For |
|
For |
|
MERCK & CO., INC.
Security |
58933Y105 |
Meeting Type |
Annual |
Ticker Symbol |
MRK |
Meeting Date |
22-May-2018 |
Record Date |
28-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Leslie A. Brun |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Thomas R. Cech |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Pamela J. Craig |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Kenneth C. Frazier |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Thomas H. Glocer |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Rochelle B. Lazarus |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: John H. Noseworthy |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Paul B. Rothman |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Patricia F. Russo |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Craig B. Thompson |
|
Management |
|
For |
|
For |
|
1k. |
|
Election of Director: Inge G. Thulin |
|
Management |
|
For |
|
For |
|
1l. |
|
Election of Director: Wendell P. Weeks |
|
Management |
|
For |
|
For |
|
1m. |
|
Election of Director: Peter C. Wendell |
|
Management |
|
For |
|
For |
|
2. |
|
Non-binding advisory vote to approve the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification of the appointment of the Companys independent registered public accounting firm for 2018. |
|
Management |
|
For |
|
For |
|
4. |
|
Shareholder proposal concerning shareholders right to act by written consent. |
|
Shareholder |
|
Against |
|
For |
|
MILESTONE PHARMACEUTICALS INC.
Security |
N/A |
Meeting Type |
Written Consent |
Ticker Symbol |
N/A |
Meeting Date |
12-Jun-2018 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Acceptance of the Audited Financial Statements of the Corporation for year ended December 31, 2017 |
|
Management |
|
For |
|
For |
|
2. |
|
Election of Directors |
|
Management |
|
For |
|
For |
|
3. |
|
Appointment of Auditors |
|
Management |
|
For |
|
For |
|
4. |
|
Transaction of other Business |
|
Management |
|
For |
|
For |
|
MYLAN N.V.
Security |
N59465109 |
Meeting Type |
Annual |
Ticker Symbol |
MYL |
Meeting Date |
29-Jun-2018 |
Record Date |
01-Jun-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1A. |
|
Appointment of Director: Heather Bresch |
|
Management |
|
For |
|
For |
|
1B. |
|
Appointment of Director: Hon. Robert J. Cindrich |
|
Management |
|
For |
|
For |
|
1C. |
|
Appointment of Director: Robert J. Coury |
|
Management |
|
For |
|
For |
|
1D. |
|
Appointment of Director: JoEllen Lyons Dillon |
|
Management |
|
For |
|
For |
|
1E. |
|
Appointment of Director: Neil Dimick, C.P.A. |
|
Management |
|
For |
|
For |
|
1F. |
|
Appointment of Director: Melina Higgins |
|
Management |
|
For |
|
For |
|
1G. |
|
Appointment of Director: Harry A. Korman |
|
Management |
|
For |
|
For |
|
1H. |
|
Appointment of Director: Rajiv Malik |
|
Management |
|
For |
|
For |
|
1I. |
|
Appointment of Director: Mark W. Parrish |
|
Management |
|
For |
|
For |
|
1J. |
|
Appointment of Director: Pauline van der Meer Mohr |
|
Management |
|
For |
|
For |
|
1K. |
|
Appointment of Director: Randall L. (Pete) Vanderveen, Ph.D. |
|
Management |
|
For |
|
For |
|
1L. |
|
Appointment of Director: Sjoerd S. Vollebregt |
|
Management |
|
For |
|
For |
|
2. |
|
Approval, on an advisory basis, of the compensation of the named executive officers of the Company |
|
Management |
|
For |
|
For |
|
3. |
|
Adoption of the Dutch annual accounts for fiscal year 2017 |
|
Management |
|
For |
|
For |
|
4. |
|
Ratification of the selection of Deloitte & Touche LLP as the Companys independent registered public accounting firm for fiscal year 2018 |
|
Management |
|
For |
|
For |
|
5. |
|
Instruction to Deloitte Accountants B.V. for the audit of the Companys Dutch statutory annual accounts for fiscal year 2018 |
|
Management |
|
For |
|
For |
|
6. |
|
Authorization of the Board to acquire shares in the capital of the Company |
|
Management |
|
For |
|
For |
|
NEW SENIOR INVESTMENT GROUP INC.
Security |
648691103 |
Meeting Type |
Annual |
Ticker Symbol |
SNR |
Meeting Date |
11-Jun-2018 |
Record Date |
19-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
Virgis W. Colbert |
|
|
|
For |
|
For |
|
|
|
2 |
C. van der H. Holstein |
|
|
|
For |
|
For |
|
2. |
|
To ratify the appointment of Ernst & Young LLP as independent registered public accounting firm for New Senior Investment Group Inc. for fiscal year 2018. |
|
Management |
|
For |
|
For |
| |
3. |
|
Non-binding stockholder proposal to adopt majority voting in uncontested elections of directors. |
|
Shareholder |
|
Abstain |
|
N/A |
|
NOVARTIS AG
Security |
66987V109 |
Meeting Type |
Annual |
Ticker Symbol |
NVS |
Meeting Date |
02-Mar-2018 |
Record Date |
19-Jan-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Approval of the Operating and Financial Review of Novartis AG, the Financial Statements of Novartis AG and the Group Consolidated Financial Statements for the 2017 Financial Year |
|
Management |
|
For |
|
For |
|
2. |
|
Discharge from Liability of the Members of the Board of Directors and the Executive Committee |
|
Management |
|
For |
|
For |
|
3. |
|
Appropriation of Available Earnings of Novartis AG as per Balance Sheet and Declaration of Dividend |
|
Management |
|
For |
|
For |
|
4. |
|
Reduction of Share Capital |
|
Management |
|
For |
|
For |
|
5A. |
|
Binding Vote on the maximum aggregate amount of Compensation for Members of the Board of Directors from the 2018 Annual General Meeting to the 2019 Annual General Meeting |
|
Management |
|
For |
|
For |
|
5B. |
|
Binding Vote on the maximum aggregate amount of Compensation for Members of the Executive Committee for the next Financial Year, i.e. 2019 |
|
Management |
|
For |
|
For |
|
5C. |
|
Advisory Vote on the 2017 Compensation Report |
|
Management |
|
For |
|
For |
|
6A. |
|
Re-election as Chairman of the Board of Director: Joerg Reinhardt, Ph.D. |
|
Management |
|
For |
|
For |
|
6B. |
|
Re-election of Director: Nancy C. Andrews, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
6C. |
|
Re-election of Director: Dimitri Azar, M.D. |
|
Management |
|
For |
|
For |
|
6D. |
|
Re-election of Director: Ton Buechner |
|
Management |
|
For |
|
For |
|
6E. |
|
Re-election of Director: Srikant Datar, Ph.D. |
|
Management |
|
For |
|
For |
|
6F. |
|
Re-election of Director: Elizabeth Doherty |
|
Management |
|
For |
|
For |
|
6G. |
|
Re-election of Director: Ann Fudge |
|
Management |
|
For |
|
For |
|
6H. |
|
Re-election of Director: Frans van Houten |
|
Management |
|
For |
|
For |
|
6I. |
|
Re-election of Director: Andreas von Planta, Ph.D. |
|
Management |
|
For |
|
For |
|
6J. |
|
Re-election of Director: Charles L. Sawyers, M.D. |
|
Management |
|
For |
|
For |
|
6K. |
|
Re-election of Director: Enrico Vanni, Ph.D. |
|
Management |
|
For |
|
For |
|
6L. |
|
Re-election of Director: William T. Winters |
|
Management |
|
For |
|
For |
|
7A. |
|
Re-election to the Compensation Committee: Srikant Datar, Ph.D. |
|
Management |
|
For |
|
For |
|
7B. |
|
Re-election to the Compensation Committee: Ann Fudge |
|
Management |
|
For |
|
For |
|
7C. |
|
Re-election to the Compensation Committee: Enrico Vanni, Ph.D. |
|
Management |
|
For |
|
For |
|
7D. |
|
Re-election to the Compensation Committee: William T. Winters |
|
Management |
|
For |
|
For |
|
8. |
|
Re-election of the Statutory Auditor |
|
Management |
|
For |
|
For |
|
9. |
|
Re-election of the Independent Proxy |
|
Management |
|
For |
|
For |
|
10. |
|
General instructions in case of alternative motions under the agenda items published in the Notice of Annual General Meeting, and/or of motions relating to additional agenda items according to Article 700 paragraph 3 of the Swiss Code of Obligations Mark FOR on this Voting Instruction Card to vote according to the motions of the Board of Directors. Mark AGAINST to vote against any alternative /new motions. Mark ABSTAIN to abstain from voting. |
|
Management |
|
For |
|
N/A |
|
NOVAVAX, INC.
Security |
670002104 |
Meeting Type |
Annual |
Ticker Symbol |
NVAX |
Meeting Date |
14-Jun-2018 |
Record Date |
18-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
Richard H. Douglas Ph.D |
|
|
|
For |
|
For |
|
|
|
2 |
Gary C. Evans |
|
|
|
For |
|
For |
|
2. |
|
To consider and vote whether to approve, on an advisory basis, the compensation paid to our Named Executive Officers. |
|
Management |
|
For |
|
For |
| |
3. |
|
To amend and restate the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, to increase the number of shares of the Companys common stock, par value $0.01, available for issuance thereunder by 20,000,000 shares. |
|
Management |
|
For |
|
For |
| |
4. |
|
To amend and restate the Novavax, Inc. Amended and Restated 2013 Employee Stock Purchase Plan, to increase the number of shares of the Companys common stock, par value $0.01, available for issuance thereunder by 4,000,000 shares. |
|
Management |
|
For |
|
For |
| |
5. |
|
To ratify the appointment of Ernst & Young LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
OMEGA HEALTHCARE INVESTORS, INC.
Security |
681936100 |
Meeting Type |
Annual |
Ticker Symbol |
OHI |
Meeting Date |
08-Jun-2018 |
Record Date |
23-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
Kapila K. Anand |
|
|
|
For |
|
For |
|
|
|
2 |
Craig M. Bernfield |
|
|
|
For |
|
For |
|
|
|
3 |
Norman R. Bobins |
|
|
|
For |
|
For |
|
|
|
4 |
Craig R. Callen |
|
|
|
For |
|
For |
|
|
|
5 |
Barbara B. Hill |
|
|
|
For |
|
For |
|
|
|
6 |
Edward Lowenthal |
|
|
|
For |
|
For |
|
|
|
7 |
Ben W. Perks |
|
|
|
For |
|
For |
|
|
|
8 |
C. Taylor Pickett |
|
|
|
For |
|
For |
|
|
|
9 |
Stephen D. Plavin |
|
|
|
For |
|
For |
|
2. |
|
Ratification of Independent Auditors Ernst & Young LLP. |
|
Management |
|
For |
|
For |
| |
3. |
|
Approval, on an Advisory Basis, of Executive Compensation. |
|
Management |
|
For |
|
For |
| |
4. |
|
Approval of 2018 Stock Incentive Plan. |
|
Management |
|
For |
|
For |
|
PERRIGO COMPANY PLC
Security |
G97822103 |
Meeting Type |
Annual |
Ticker Symbol |
PRGO |
Meeting Date |
04-May-2018 |
Record Date |
06-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Bradley A. Alford |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Laurie Brlas |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Rolf A. Classon |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Gary M. Cohen |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Adriana Karaboutis |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Jeffrey B. Kindler |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Donal OConnor |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Geoffrey M. Parker |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Uwe F. Roehrhoff |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Theodore R. Samuels |
|
Management |
|
For |
|
For |
|
1k. |
|
Election of Director: Jeffrey C. Smith |
|
Management |
|
For |
|
For |
|
2. |
|
Ratify the appointment of Ernst & Young LLP as our independent auditor for the period ending December 31, 2018, and authorize the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory vote on the Companys executive compensation. |
|
Management |
|
For |
|
For |
|
4. |
|
Renew the Boards authority to issue shares under Irish law. |
|
Management |
|
For |
|
For |
|
5. |
|
Renew the Boards authority to opt-out of statutory pre- emption rights under Irish law. |
|
Management |
|
For |
|
For |
|
PFIZER INC.
Security |
717081103 |
Meeting Type |
Annual |
Ticker Symbol |
PFE |
Meeting Date |
26-Apr-2018 |
Record Date |
27-Feb-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Dennis A. Ausiello |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Ronald E. Blaylock |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Albert Bourla |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: W. Don Cornwell |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Joseph J. Echevarria |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Helen H. Hobbs |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: James M. Kilts |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Dan R. Littman |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Shantanu Narayen |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Suzanne Nora Johnson |
|
Management |
|
For |
|
For |
|
1k. |
|
Election of Director: Ian C. Read |
|
Management |
|
For |
|
For |
|
1l. |
|
Election of Director: James C. Smith |
|
Management |
|
For |
|
For |
|
2. |
|
Ratify the selection of KPMG LLP as independent registered public accounting firm for 2018 |
|
Management |
|
For |
|
For |
|
3. |
|
2018 Advisory approval of executive compensation |
|
Management |
|
For |
|
For |
|
4. |
|
Approval of the Pfizer Inc. French Sub-Plan under the 2014 Stock Plan |
|
Management |
|
For |
|
For |
|
5. |
|
Shareholder proposal regarding right to act by written consent |
|
Shareholder |
|
Against |
|
For |
|
6. |
|
Shareholder proposal regarding independent chair policy |
|
Shareholder |
|
Against |
|
For |
|
7. |
|
Shareholder proposal regarding report on lobbying activities |
|
Shareholder |
|
Against |
|
For |
|
QUORUM HEALTH CORPORATION
Security |
74909E106 |
Meeting Type |
Annual |
Ticker Symbol |
QHC |
Meeting Date |
08-Jun-2018 |
Record Date |
20-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: James T. Breedlove |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Joseph A. Hastings, D.M.D. |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Thomas D. Miller |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Barbara R. Paul, M.D. |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Terry Allison Rappuhn |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Alice D. Schroeder |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: R. Lawrence Van Horn, Ph.D. |
|
Management |
|
For |
|
For |
|
2. |
|
To approve the compensation of the Companys named executive officers, as disclosed in the Proxy Statement. |
|
Management |
|
For |
|
For |
|
3. |
|
To ratify the appointment of Deloitte & Touche LLP as the Companys independent registered public accounting firm (independent auditors) for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
REGENERON PHARMACEUTICALS, INC.
Security |
75886F107 |
Meeting Type |
Annual |
Ticker Symbol |
REGN |
Meeting Date |
08-Jun-2018 |
Record Date |
12-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1.1 |
|
Election of Director: Arthur F. Ryan |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election of Director: George L. Sing |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election of Director: Marc Tessier-Lavigne |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification of the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
SABRA HEALTH CARE REIT, INC.
Security |
78573L106 |
Meeting Type |
Special |
Ticker Symbol |
SBRA |
Meeting Date |
15-Aug-2017 |
Record Date |
29-Jun-2017 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
TO APPROVE THE ISSUANCE OF SABRA HEALTH CARE REIT, INC. (SABRA) COMMON STOCK IN CONNECTION WITH THE MERGER (THE MERGER) OF CARE CAPITAL PROPERTIES, INC., A DELAWARE CORPORATION (CCP), WITH AND INTO PR SUB, LLC, A DELAWARE LIMITED LIABILITY COMPANY AND WHOLLY-OWNED SUBSIDIARY OF SABRA (MERGER SUB), WITH MERGER SUB CONTINUING AS THE SURVIVING COMPANY IN THE MERGER, PURSUANT TO THE AGREEMENT AND PLAN OF MERGER, DATED AS OF MAY 7, 2017, BY AND AMONG ...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL). |
|
Management |
|
For |
|
For |
|
2. |
|
TO APPROVE THE ADJOURNMENT OF THE SABRA SPECIAL MEETING FROM TIME TO TIME, IF NECESSARY OR APPROPRIATE, INCLUDING TO SOLICIT ADDITIONAL PROXIES IN FAVOR OF THE SABRA COMMON STOCK ISSUANCE PROPOSAL IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF SUCH ADJOURNMENT TO APPROVE SUCH PROPOSAL. |
|
Management |
|
For |
|
For |
|
SABRA HEALTH CARE REIT, INC.
Security |
78573L106 |
Meeting Type |
Annual |
Ticker Symbol |
SBRA |
Meeting Date |
21-Jun-2018 |
Record Date |
16-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Craig A. Barbarosh |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Robert A. Ettl |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Michael J. Foster |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Ronald G. Geary |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Raymond J. Lewis |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Jeffrey A. Malehorn |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Richard K. Matros |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Milton J. Walters |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification of the appointment of PricewaterhouseCoopers LLP as Sabras independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
Approval, on an advisory basis, of the compensation of Sabras named executive officers. |
|
Management |
|
For |
|
For |
|
SAGE THERAPEUTICS, INC.
Security |
78667J108 |
Meeting Type |
Annual |
Ticker Symbol |
SAGE |
Meeting Date |
06-Jun-2018 |
Record Date |
09-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
Geno Germano |
|
|
|
For |
|
For |
|
|
|
2 |
Steven Paul |
|
|
|
For |
|
For |
|
2. |
|
To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018. |
|
Management |
|
For |
|
For |
| |
3. |
|
Approve, on an advisory basis, the compensation of the named executive officers. |
|
Management |
|
For |
|
For |
|
SANOFI
Security |
80105N105 |
Meeting Type |
Annual |
Ticker Symbol |
SNY |
Meeting Date |
02-May-2018 |
Record Date |
28-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Approval of the individual company financial statements for the year ended December 31, 2017. |
|
Management |
|
For |
|
For |
|
2. |
|
Approval of the consolidated financial statements for the year ended December 31, 2017. |
|
Management |
|
For |
|
For |
|
3. |
|
Appropriation of profits for the year ended December 31, 2017 and declaration of dividend |
|
Management |
|
For |
|
For |
|
4. |
|
Reappointment of Olivier Brandicourt as a Director |
|
Management |
|
For |
|
For |
|
5. |
|
Reappointment of Patrick Kron as a Director |
|
Management |
|
For |
|
For |
|
6. |
|
Reappointment of Christian Mulliez as a Director |
|
Management |
|
For |
|
For |
|
7. |
|
Appointment of Emmanuel Babeau as a Director |
|
Management |
|
For |
|
For |
|
8. |
|
Compensation policy for the Chairman of the Board of Directors |
|
Management |
|
For |
|
For |
|
9. |
|
Compensation policy for the Chief Executive Officer |
|
Management |
|
For |
|
For |
|
10. |
|
Approval of the payment in respect of the year ended December 31, 2017 and of the award of fixed, variable and exceptional components of the total compensation and benefits of whatever kind to Serge Weinberg, Chairman of the Board of Directors |
|
Management |
|
For |
|
For |
|
11. |
|
Approval of the payment in respect of the year ended December 31, 2017 and of the award of fixed, variable and exceptional components of the total compensation and benefits of whatever kind to Olivier Brandicourt, Chief Executive Officer |
|
Management |
|
For |
|
For |
|
12. |
|
Reappointment of Ernst & Young et Autres as a Statutory Auditor |
|
Management |
|
For |
|
For |
|
13. |
|
Authorization to the Board of Directors to carry out transactions in the Companys shares (except during public tender offers) |
|
Management |
|
For |
|
For |
|
14. |
|
Amendments of Articles 11 and 12 of the Articles of Association |
|
Management |
|
For |
|
For |
|
15. |
|
Powers for formalities |
|
Management |
|
For |
|
For |
|
SAREPTA THERAPEUTICS INC.
Security |
803607100 |
Meeting Type |
Annual |
Ticker Symbol |
SRPT |
Meeting Date |
06-Jun-2018 |
Record Date |
11-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1A |
|
ELECTION OF GROUP I DIRECTOR: Michael W. Bonney |
|
Management |
|
For |
|
For |
|
1B |
|
ELECTION OF GROUP I DIRECTOR: Douglas S. Ingram |
|
Management |
|
For |
|
For |
|
1C |
|
ELECTION OF GROUP I DIRECTOR: Hans Wigzell, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
2. |
|
ADVISORY VOTE TO APPROVE, ON A NON-BINDING BASIS, NAMED EXECUTIVE OFFICER COMPENSATION |
|
Management |
|
For |
|
For |
|
3. |
|
APPROVAL OF THE COMPANYS 2018 EQUITY INCENTIVE PLAN |
|
Management |
|
For |
|
For |
|
4. |
|
RATIFICATION OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2018 |
|
Management |
|
For |
|
For |
|
SENIOR HOUSING PROPERTIES TRUST
Security |
81721M109 |
Meeting Type |
Annual |
Ticker Symbol |
SNH |
Meeting Date |
22-May-2018 |
Record Date |
01-Feb-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1.1 |
|
Election of Trustee: Lisa Harris Jones (for Independent Trustee in Class I) |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election of Trustee: Jennifer B. Clark (for Managing Trustee in Class I) |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory vote to approve executive compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification of the appointment of Ernst & Young LLP as independent auditors to serve for the 2018 fiscal year. |
|
Management |
|
For |
|
For |
|
SHIRE PLC
Security |
82481R106 |
Meeting Type |
Annual |
Ticker Symbol |
SHPG |
Meeting Date |
24-Apr-2018 |
Record Date |
22-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
To receive the Companys Annual Report and Accounts for the year ended December 31, 2017. |
|
Management |
|
For |
|
For |
|
2. |
|
To approve the Directors Remuneration Report, excluding the Directors Remuneration Policy, set out on pages 78 to 108 of the Annual Report and Accounts for the year ended December 31, 2017. |
|
Management |
|
For |
|
For |
|
3. |
|
To approve the Directors Remuneration Policy, contained within the Directors Remuneration Report and set out on pages 86 to 95 of the Annual Report and Accounts for the year ended December 31, 2017, to take effect after the end of the Annual General Meeting on April 24, 2018. |
|
Management |
|
For |
|
For |
|
4. |
|
To re-elect Olivier Bohuon as a Director. |
|
Management |
|
For |
|
For |
|
5. |
|
To re-elect Ian Clark as a Director. |
|
Management |
|
For |
|
For |
|
6. |
|
To elect Thomas Dittrich as a Director. |
|
Management |
|
For |
|
For |
|
7. |
|
To re-elect Gail Fosler as a Director. |
|
Management |
|
For |
|
For |
|
8. |
|
To re-elect Steven Gillis as a Director. |
|
Management |
|
For |
|
For |
|
9. |
|
To re-elect David Ginsburg as a Director. |
|
Management |
|
For |
|
For |
|
10. |
|
To re-elect Susan Kilsby as a Director. |
|
Management |
|
For |
|
For |
|
11. |
|
To re-elect Sara Mathew as a Director. |
|
Management |
|
For |
|
For |
|
12. |
|
To re-elect Flemming Ornskov as a Director. |
|
Management |
|
For |
|
For |
|
13. |
|
To re-elect Albert Stroucken as a Director. |
|
Management |
|
For |
|
For |
|
14. |
|
To re-appoint Deloitte LLP as the Companys Auditor until the conclusion of the next Annual General Meeting of the Company. |
|
Management |
|
For |
|
For |
|
15. |
|
To authorize the Audit, Compliance & Risk Committee to determine the remuneration of the Auditor. |
|
Management |
|
For |
|
For |
|
16. |
|
That the authority to allot Relevant Securities (as defined in the Companys Articles of Association (the Articles)) conferred on the Directors by Article 10 paragraph (B) of the Articles be renewed and for this purpose the Authorised Allotment Amount shall be: (a) GBP 15,187,600.85 of Relevant Securities. (b) solely in connection with an allotment pursuant to an offer by way of a Rights Issue (as defined in the Articles, but only if and to the extent that such offer is ...(due to space limits, see proxy material for full proposal). |
|
Management |
|
For |
|
For |
|
17. |
|
That, subject to the passing of Resolution 16, the authority to allot equity securities (as defined in the Companys Articles of Association (the Articles)) wholly for cash conferred on the Directors by Article 10 paragraph (D) of the Articles be renewed and for this purpose the Non Pre-emptive Amount (as defined in the Articles) shall be GBP 2,278,140.10 and the Allotment Period shall be the period commencing on April 24, 2018, and ending on the earlier of the close of business on ...(due to space limits, see proxy material for full proposal). |
|
Management |
|
For |
|
For |
|
18. |
|
That, subject to the passing of Resolutions 16 and 17 and for the purpose of the authority to allot equity securities (as defined in the Companys Articles of Association (the Articles)) wholly for cash conferred on the Directors by Article 10 paragraph (D) of the Articles and renewed by Resolution 17, the Non Pre-emptive Amount (as defined in the Articles) shall be increased from GBP 2,278,140.10 to GBP ...(due to space limits, see proxy material for full proposal). |
|
Management |
|
For |
|
For |
|
19. |
|
That the Company be and is hereby generally and unconditionally authorized: (a) pursuant to Article 57 of the Companies (Jersey) Law 1991 to make market purchases of Ordinary Shares in the capital of the Company, provided that: (1) the maximum number of Ordinary Shares hereby authorized to be purchased is 91,125,605; (2) the minimum price, exclusive of any expenses, which may be paid for an Ordinary Share is five pence; (3) the maximum price, exclusive of any expenses, which may be paid ...(due to space limits, see proxy material for full proposal). |
|
Management |
|
For |
|
For |
|
20. |
|
To approve that a general meeting of the Company, other than an annual general meeting, may be called on not less than 14 clear days notice. |
|
Management |
|
For |
|
For |
|
SMITH & NEPHEW PLC
Security |
83175M205 |
Meeting Type |
Annual |
Ticker Symbol |
SNN |
Meeting Date |
12-Apr-2018 |
Record Date |
23-Feb-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
To receive the audited accounts |
|
Management |
|
For |
|
For |
|
2. |
|
To approve the Directors Remuneration Report (excluding policy) |
|
Management |
|
For |
|
For |
|
3. |
|
To declare a final dividend |
|
Management |
|
For |
|
For |
|
4. |
|
Election of Director: Graham Baker |
|
Management |
|
For |
|
For |
|
5. |
|
Election of Director: Vinita Bali |
|
Management |
|
For |
|
For |
|
6. |
|
Election of Director: Ian Barlow |
|
Management |
|
For |
|
For |
|
7. |
|
Election of Director: Olivier Bohuon |
|
Management |
|
For |
|
For |
|
8. |
|
Election of Director: The Rt. Hon Baroness Virginia Bottomley |
|
Management |
|
For |
|
For |
|
9. |
|
Election of Director: Erik Engstrom |
|
Management |
|
For |
|
For |
|
10. |
|
Election of Director: Roland Diggelmann |
|
Management |
|
For |
|
For |
|
11. |
|
Election of Director: Robin Freestone |
|
Management |
|
For |
|
For |
|
12. |
|
Election of Director: Michael Friedman |
|
Management |
|
For |
|
For |
|
13. |
|
Election of Director: Marc Owen |
|
Management |
|
For |
|
For |
|
14. |
|
Election of Director: Angie Risley |
|
Management |
|
For |
|
For |
|
15. |
|
Election of Director: Roberto Quarta |
|
Management |
|
For |
|
For |
|
16. |
|
To re-appoint the Auditor |
|
Management |
|
For |
|
For |
|
17. |
|
To authorise the Directors to determine the remuneration of the Auditor |
|
Management |
|
For |
|
For |
|
18. |
|
To renew the Directors authority to allot shares |
|
Management |
|
For |
|
For |
|
19. |
|
To renew the Directors authority for the disapplication of the pre-emption rights |
|
Management |
|
For |
|
For |
|
20. |
|
To renew the Directors limited authority to make market purchases of the Companys own shares |
|
Management |
|
For |
|
For |
|
21. |
|
To authorise general meetings to be held on 14 clear days notice |
|
Management |
|
For |
|
For |
|
SOSEI GROUP CORPORATION
Security |
J7637L109 |
Meeting Type |
Annual General Meeting |
Ticker Symbol |
4565.T |
Meeting Date |
22-Jun-2018 |
Record Date |
31-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
|
|
Please reference meeting materials. |
|
Non-Voting |
|
N/A |
|
N/A |
|
1 |
|
Amend Articles to: Adopt Reduction of Liability System for Non-Executive Directors, Change Fiscal Year End to the end of December and Record Date for Interim Dividends to the end of June |
|
Management |
|
For |
|
For |
|
2.1 |
|
Appoint a Director Tamura, Shinichi |
|
Management |
|
For |
|
For |
|
2.2 |
|
Appoint a Director Peter Bains |
|
Management |
|
For |
|
For |
|
2.3 |
|
Appoint a Director Toyama, Tomohiro |
|
Management |
|
For |
|
For |
|
2.4 |
|
Appoint a Director Julia Gregory |
|
Management |
|
For |
|
For |
|
2.5 |
|
Appoint a Director Michael Hayden |
|
Management |
|
For |
|
For |
|
2.6 |
|
Appoint a Director Kaga, Kuniaki |
|
Management |
|
For |
|
For |
|
2.7 |
|
Appoint a Director David Roblin |
|
Management |
|
For |
|
For |
|
3 |
|
Appoint Accounting Auditors |
|
Management |
|
For |
|
For |
|
STERIS PLC
Security |
G84720104 |
Meeting Type |
Annual |
Ticker Symbol |
STE |
Meeting Date |
31-Jul-2018 |
Record Date |
30-May-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Re-election of Director: Richard C. Breeden |
|
Management |
|
For |
|
For |
|
1b. |
|
Re-election of Director: Cynthia L. Feldmann |
|
Management |
|
For |
|
For |
|
1c. |
|
Re-election of Director: Dr. Jacqueline B. Kosecoff |
|
Management |
|
For |
|
For |
|
1d. |
|
Re-election of Director: David B. Lewis |
|
Management |
|
For |
|
For |
|
1e. |
|
Re-election of Director: Sir Duncan K. Nichol |
|
Management |
|
For |
|
For |
|
1f. |
|
Re-election of Director: Walter M Rosebrough, Jr. |
|
Management |
|
For |
|
For |
|
1g. |
|
Re-election of Director: Dr. Nirav R. Shah |
|
Management |
|
For |
|
For |
|
1h. |
|
Re-election of Director: Dr. Mohsen M. Sohi |
|
Management |
|
For |
|
For |
|
1i. |
|
Re-election of Director: Dr. Richard M. Steeves |
|
Management |
|
For |
|
For |
|
1j. |
|
Re-election of Director: Loyal W. Wilson |
|
Management |
|
For |
|
For |
|
1k. |
|
Re-election of Director: Dr. Michael B. Wood |
|
Management |
|
For |
|
For |
|
2. |
|
To ratify the appointment of Ernst & Young LLP as the Companys independent registered public accounting firm for the year ending March 31, 2019. |
|
Management |
|
For |
|
For |
|
3. |
|
To appoint Ernst & Young LLP as the Companys U.K. statutory auditor under the Act to hold office until the conclusion of the Companys next Annual General Meeting. |
|
Management |
|
For |
|
For |
|
4. |
|
To authorize the Directors of the Company or the Audit Committee to determine the remuneration of Ernst & Young LLP as the Companys U.K. statutory auditor. |
|
Management |
|
For |
|
For |
|
5. |
|
To approve, on a non-binding advisory basis, the compensation of the Companys named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Companys Proxy Statement dated June 12, 2018. |
|
Management |
|
For |
|
For |
|
6. |
|
To approve, on a non-binding advisory basis, the Director Remuneration Report for the period ended March 31, 2018 contained within the Companys U.K. annual report and accounts for the year ended March 31, 2018. |
|
Management |
|
For |
|
For |
|
STRYKER CORPORATION
Security |
863667101 |
Meeting Type |
Annual |
Ticker Symbol |
SYK |
Meeting Date |
02-May-2018 |
Record Date |
05-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Mary K. Brainerd |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Srikant M. Datar, Ph.D. |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Roch Doliveux, DVM |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Louise L. Francesconi |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Allan C. Golston (Lead Independent Director) |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Kevin A. Lobo (Chairman of the Board) |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Sherilyn S. McCoy |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Andrew K. Silvernail |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Ronda E. Stryker |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Rajeev Suri |
|
Management |
|
For |
|
For |
|
2. |
|
Ratify appointment of Ernst & Young LLP as our independent registered public accounting firm for 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory vote to approve named executive officer compensation. |
|
Management |
|
For |
|
For |
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Security |
881624209 |
Meeting Type |
Annual |
Ticker Symbol |
TEVA |
Meeting Date |
05-Jun-2018 |
Record Date |
26-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1.1 |
|
Election of Director: Rosemary A. Crane |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election of Director: Gerald M. Lieberman |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election of Director: Professor Ronit Satchi-Fainaro |
|
Management |
|
For |
|
For |
|
2. |
|
To approve, on a non-binding advisory basis, the compensation for Tevas named executive officers. |
|
Management |
|
For |
|
For |
|
3. |
|
To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensation for Tevas named executive officers every one, two or three years. |
|
Management |
|
1 Year |
|
For |
|
4. |
|
To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Tevas independent registered public accounting firm until the 2019 annual meeting of shareholders. |
|
Management |
|
For |
|
For |
|
5. |
|
To approve an amendment and restatement of Tevas 2008 Employee Stock Purchase Plan for U.S. Employees. |
|
Management |
|
For |
|
For |
|
THE RMR GROUP INC.
Security |
74967R106 |
Meeting Type |
Annual |
Ticker Symbol |
RMR |
Meeting Date |
28-Mar-2018 |
Record Date |
17-Jan-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1.1 |
|
Election of Director: Ann Logan |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election of Director: Rosen Plevneliev |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election of Director: Adam D. Portnoy |
|
Management |
|
For |
|
For |
|
1.4 |
|
Election of Director: Barry M. Portnoy |
|
Management |
|
For |
|
For |
|
1.5 |
|
Election of Director: Walter C. Watkins, Jr. |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification of the appointment of Ernst & Young LLP as independent auditors to serve for the 2018 fiscal year. |
|
Management |
|
For |
|
For |
|
UCB SA
Security |
B93562120 |
Meeting Type |
MIX |
Ticker Symbol |
UCB.BR |
Meeting Date |
26-Apr-2018 |
Record Date |
12-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
O.1 |
|
REPORT OF THE BOARD OF DIRECTORS ON THE ANNUAL ACCOUNTS FOR THE FINANCIAL-YEAR ENDED 31 DECEMBER 2017 |
|
Non-Voting |
|
N/A |
|
N/A |
|
O.2 |
|
REPORT OF THE STATUTORY AUDITOR ON THE ANNUAL ACCOUNTS FOR THE FINANCIAL YEAR- ENDED 31 DECEMBER 2017 |
|
Non-Voting |
|
N/A |
|
N/A |
|
O.3 |
|
COMMUNICATION OF THE CONSOLIDATED ANNUAL ACCOUNTS OF THE UCB GROUP RELATING-TO THE FINANCIAL YEAR ENDED 31 DECEMBER 2017 |
|
Non-Voting |
|
N/A |
|
N/A |
|
O.4 |
|
THE GENERAL MEETING APPROVES THE ANNUAL ACCOUNTS OF UCB SA/NV FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2017 AND THE APPROPRIATION OF THE RESULTS REFLECTED THEREIN, INCLUDING THE APPROVAL OF A GROSS DIVIDEND OF EUR 1,18 PER SHARE |
|
Management |
|
For |
|
For |
|
O.5 |
|
THE GENERAL MEETING APPROVES THE REMUNERATION REPORT FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2017. |
|
Management |
|
For |
|
For |
|
O.6 |
|
THE GENERAL MEETING GRANTS DISCHARGE TO THE DIRECTORS FOR THE PERFORMANCE OF THEIR DUTIES DURING THE FINANCIAL YEAR ENDED 31 DECEMBER 2017 |
|
Management |
|
For |
|
For |
|
O.7 |
|
THE GENERAL MEETING GRANTS DISCHARGE TO THE STATUTORY AUDITOR FOR THE PERFORMANCE OF HIS DUTIES DURING THE FINANCIAL YEAR ENDED 31 DECEMBER 2017 |
|
Management |
|
For |
|
For |
|
O.8.1 |
|
THE GENERAL MEETING RENEWS THE APPOINTMENT OF DR. JEAN-CHRISTOPHE TELLIER AS DIRECTOR FOR A TERM OF FOUR YEARS UNTIL THE CLOSE OF THE ANNUAL GENERAL MEETING OF 2022 |
|
Management |
|
For |
|
For |
|
O.82A |
|
THE GENERAL MEETING RENEWS THE APPOINTMENT OF PROF. KAY DAVIES AS DIRECTOR FOR A TERM OF FOUR YEARS UNTIL THE CLOSE OF THE ANNUAL GENERAL MEETING OF 2022 |
|
Management |
|
For |
|
For |
|
O.82B |
|
THE GENERAL MEETING ACKNOWLEDGES THAT, FROM THE INFORMATION MADE AVAILABLE TO THE COMPANY, KAY DAVIES QUALIFIES AS AN INDEPENDENT DIRECTOR ACCORDING TO THE INDEPENDENCE CRITERIA PROVIDED FOR BY ARTICLE 526TER OF THE BELGIAN COMPANIES CODE AND THE APPLICABLE CORPORATE GOVERNANCE RULES AND APPOINTS HER AS INDEPENDENT DIRECTOR |
|
Management |
|
For |
|
For |
|
O.8.3 |
|
THE GENERAL MEETING RENEWS THE APPOINTMENT OF MR. CEDRIC VAN RIJCKEVORSEL AS DIRECTOR FOR A TERM OF FOUR YEARS UNTIL THE CLOSE OF THE ANNUAL GENERAL MEETING OF 2022 |
|
Management |
|
For |
|
For |
|
O.9 |
|
STATUTORY AUDITOR - RENEWAL OF THE MANDATE: UPON THE PROPOSAL OF THE AUDIT COMMITTEE AND UPON PRESENTATION BY THE WORKS COUNCIL, THE GENERAL MEETING RENEWS THE APPOINTMENT OF PWC BEDRIJFSREVISOREN BCVBA / REVISEURS DENTREPRISES SCCRL, HAVING ITS REGISTERED OFFICE AT 1932 SINT-STEVENS-WOLUWE, WOLUWEDAL 18, AS STATUTORY AUDITOR FOR A TERM OF THREE (3) YEARS, UP TO AND INCLUDING THE GENERAL MEETING CONVENED TO DECIDE ON THE ANNUAL ACCOUNTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2020. THE PERMANENT REPRESENTATIVE OF PWC BEDRIJFSREVISOREN BCVBA / REVISEURS DENTREPRISES SCCRL WILL BE MR. ROMAIN SEFFER, REGISTERED AUDITOR. THE STATUTORY AUDITORS ANNUAL FEE, FOR THE AUDIT OF THE ANNUAL AND CONSOLIDATED ACCOUNTS, IS FIXED AT EUR 435 000 (PLUS VAT, OUT-OF-POCKET EXPENSES AND THE IRE/IBR FEE) |
|
Management |
|
For |
|
For |
|
O10.1 |
|
LONG TERM INCENTIVE PLANS: THE GENERAL MEETING APPROVES THE DECISION OF THE BOARD OF DIRECTORS TO ALLOCATE AN ESTIMATED NUMBER OF 1 098 000 FREE SHARES: - OF WHICH AN ESTIMATED NUMBER OF 955 000 SHARES TO ELIGIBLE EMPLOYEES, NAMELY TO ABOUT 1 760 INDIVIDUALS (EXCLUDING NEW HIRES AND PROMOTED EMPLOYEES UP TO AND INCLUDING 1 APRIL 2018), ACCORDING TO THE APPLICABLE ALLOCATION CRITERIA. THESE FREE SHARES WILL ONLY VEST IF AND WHEN THE ELIGIBLE EMPLOYEES ARE STILL EMPLOYED WITHIN THE UCB GROUP THREE YEARS AFTER THE GRANT OF AWARDS; - OF WHICH AN ESTIMATED NUMBER OF 143 000 SHARES TO UPPER MANAGEMENT EMPLOYEES UNDER THE PERFORMANCE SHARE PLAN, NAMELY TO ABOUT 54 INDIVIDUALS, ACCORDING TO THE APPLICABLE ALLOCATION CRITERIA. THESE FREE SHARES WILL BE DELIVERED AFTER A THREE YEAR VESTING PERIOD AND THE NUMBER OF SHARES ACTUALLY ALLOCATED WILL VARY FROM 0% TO 150% OF THE NUMBER OF SHARES INITIALLY GRANTED DEPENDING ON THE LEVEL OF ACHIEVEMENT OF THE PERFORMANCE CONDITIONS SET BY THE BOARD OF UCB SA/NV AT THE MOMENT OF GRANT. THESE ESTIMATED FIGURES DO NOT TAKE INTO ACCOUNT EMPLOYEES HIRED OR PROMOTED TO ELIGIBLE LEVELS BETWEEN 1 JANUARY 2018 AND 1 APRIL 2018 |
|
Management |
|
For |
|
For |
|
O11.1 |
|
CHANGE OF CONTROL PROVISIONS - ART. 556 BELGIAN COMPANIES CODE: PURSUANT TO ARTICLE 556 OF THE BELGIAN COMPANIES CODE, THE GENERAL MEETING RENEWS ITS APPROVAL: (I) OF CONDITION 5 (E) (I) OF THE TERMS AND CONDITIONS OF THE EMTN PROGRAM (REDEMPTION AT THE OPTION OF NOTEHOLDERS - UPON A CHANGE OF CONTROL (CHANGE OF CONTROL PUT)), IN RESPECT OF ANY SERIES OF NOTES TO WHICH SUCH CONDITION IS MADE APPLICABLE BEING ISSUED UNDER THE PROGRAM FROM 26 APRIL 2018 UNTIL 25 APRIL 2019, UNDER WHICH ANY AND ALL OF THE HOLDERS OF THE RELEVANT NOTES CAN, IN CERTAIN CIRCUMSTANCES WHEN A CHANGE OF CONTROL AT THE LEVEL OF UCB SA/NV OCCURS, REQUIRE UCB SA/NV TO REDEEM THAT NOTE ON THE CHANGE OF CONTROL PUT DATE AT THE PUT REDEMPTION AMOUNT TOGETHER, IF APPROPRIATE, WITH INTEREST ACCRUED TO SUCH CHANGE OF CONTROL PUT DATE, FOLLOWING A CHANGE OF CONTROL OF UCB SA/NV; AND (II) OF ANY OTHER PROVISION OF THE EMTN PROGRAM OR NOTES ISSUED UNDER THE EMTN PROGRAM GRANTING RIGHTS TO THIRD PARTIES WHICH COULD AFFECT AN OBLIGATION ON UCB SA/NV WHERE IN EACH CASE THE EXERCISE OF THESE RIGHTS IS DEPENDENT ON THE OCCURRENCE OF A CHANGE OF CONTROL |
|
Management |
|
For |
|
For |
|
O11.2 |
|
CHANGE OF CONTROL PROVISIONS PURSUANT TO ARTICLE 556 OF THE BELGIAN COMPANIES CODE, THE GENERAL MEETING APPROVES THE CHANGE OF CONTROL CLAUSES AS PROVIDED FOR IN THE REVOLVING FACILITY AGREEMENT, AS LAST AMENDED AND RESTATED ON 9 JANUARY 2018, UNDER WHICH ANY AND ALL OF THE LENDERS CAN, IN CERTAIN CIRCUMSTANCES, CANCEL THEIR COMMITMENTS AND REQUIRE REPAYMENT OF THEIR PARTICIPATIONS IN THE LOANS, TOGETHER WITH ACCRUED INTEREST AND ALL OTHER AMOUNTS ACCRUED AND OUTSTANDING THEREUNDER, FOLLOWING A CHANGE OF CONTROL OF THE COMPANY. THE GENERAL MEETING APPROVES CLAUSE 10.2 (CHANGE OF CONTROL) OF THE REVOLVING FACILITY AGREEMENT AND ALL OTHER PROVISIONS OF THE FACILITY AGREEMENT AND ANY OTHER FINANCE DOCUMENT (AS DEFINED IN THE REVOLVING FACILITY AGREEMENT) THAT CONFER CERTAIN RIGHTS ON THIRD PARTIES WHICH HAVE AN IMPACT ON THE COMPANYS ASSETS OR RESULT IN A DEBT OR AN OBLIGATION FOR THE COMPANY IN CASE THE EXERCISE OF SUCH RIGHTS IS DEPENDENT ON A CHANGE OF CONTROL OVER THE COMPANY |
|
Management |
|
Against |
|
Against |
|
O11.3 |
|
CHANGE OF CONTROL PROVISIONS - ART. 556 BELGIAN COMPANIES CODE: PURSUANT TO ARTICLE 556 OF THE COMPANIES CODE, THE GENERAL MEETING APPROVES, IN AS FAR AS NEEDED AND APPLICABLE, THE TERMS AND CONDITIONS OF THE STOCK OPTION PLANS, STOCK AWARD PLANS AND PERFORMANCE SHARE PLANS TO SELECTED EMPLOYEES OF THE UCB GROUP, IN SO FAR THEY MAY GRANT RIGHTS THAT HAVE AN IMPACT ON THE COMPANYS ASSETS OR RESULT IN A DEBT OR AN OBLIGATION FOR THE COMPANY IN CASE THE EXERCISE OF SUCH RIGHTS IS DEPENDENT ON A CHANGE OF CONTROL OVER THE COMPANY |
|
Management |
|
For |
|
For |
|
E.1 |
|
SPECIAL REPORT OF THE BOARD OF DIRECTORS: SUBMISSION OF THE SPECIAL REPORT PREPARED BY THE BOARD OF DIRECTORS IN ACCORDANCE WITH ARTICLE 604 OF THE-BELGIAN COMPANIES CODE IN WHICH THE BOARD REQUESTS THE RENEWAL OF ITS POWERS IN RELATION TO THE AUTHORIZED CAPITAL AND INDICATES THE SPECIAL CIRCUMSTANCES WHERE IT MAY USE ITS POWERS UNDER THE AUTHORIZED CAPITAL AND THE PURPOSES THAT IT SHALL PURSUE |
|
Non-Voting |
|
|
|
|
|
E.2 |
|
RENEWAL OF THE POWERS OF THE BOARD OF DIRECTORS UNDER THE AUTHORIZED CAPITAL AND AMENDMENT TO ARTICLE 6 OF THE ARTICLES OF ASSOCIATION: THE GENERAL MEETING RESOLVES TO RENEW THE TWO YEAR AUTHORIZATION TO THE BOARD OF DIRECTORS TO INCREASE THE CAPITAL OF THE COMPANY WITHIN THE FRAMEWORK OF THE AUTHORIZED CAPITAL FOR ANOTHER TWO (2) YEARS, AND TO AMEND THE RELEVANT PARAGRAPH OF ARTICLE 6 OF THE ARTICLES OF ASSOCIATION ACCORDINGLY TO REFLECT THIS RENEWAL. SUBJECT TO THE APPROVAL OF THIS RESOLUTION, THE TEXT OF ARTICLE 6 OF THE ARTICLES OF ASSOCIATION OF THE COMPANY WILL BE AMENDED AS FOLLOWS: ARTICLE 6 THE CAPITAL OF THE COMPANY CAN BE INCREASED ONE OR MORE TIMES BY A DECISION OF A GENERAL MEETING OF SHAREHOLDERS CONSTITUTED UNDER THE CONDITIONS REQUIRED TO MODIFY THE ARTICLES OF ASSOCIATION. THE BOARD OF DIRECTORS IS AUTHORIZED TO INCREASE THE COMPANYS SHARE CAPITAL AMONGST OTHER BY WAY OF THE ISSUANCE OF SHARES, CONVERTIBLE BONDS OR WARRANTS, IN ONE OR MORE TRANSACTIONS, WITHIN THE LIMITS SET BY LAW, I. WITH UP TO 5% OF THE SHARE CAPITAL AT THE TIME OF THE DECISION OF THE BOARD OF DIRECTORS TO MAKE USE OF THIS AUTHORIZATION, IN THE EVENT OF A CAPITAL INCREASE WITH CANCELLATION OR LIMITATION OF THE PREFERENTIAL SUBSCRIPTION RIGHTS OF THE SHAREHOLDERS (WHETHER OR NOT FOR THE BENEFIT OF ONE OR MORE SPECIFIC PERSONS WHO ARE NOT EMPLOYEES OF THE COMPANY OR OF ITS SUBSIDIARIES), II. WITH UP TO 10% OF THE SHARE CAPITAL AT THE TIME OF THE DECISION OF THE BOARD OF DIRECTORS TO MAKE USE OF THIS AUTHORIZATION, IN THE EVENT OF A CAPITAL INCREASE WITHOUT CANCELLATION OR LIMITATION OF THE PREFERENTIAL SUBSCRIPTION RIGHTS OF THE EXISTING SHAREHOLDERS. IN ANY EVENT, THE TOTAL AMOUNT BY WHICH THE BOARD OF DIRECTORS MAY INCREASE THE COMPANYS SHARE CAPITAL BY A COMBINATION OF THE AUTHORIZATIONS SET FORTH IN (I) AND (II) ABOVE, IS LIMITED TO 10% OF THE SHARE CAPITAL AT THE TIME OF THE DECISION OF THE BOARD OF DIRECTORS TO MAKE USE OF THIS AUTHORIZATION. THE BOARD OF DIRECTORS IS MOREOVER EXPRESSLY AUTHORIZED TO MAKE USE OF THIS AUTHORIZATION, WITHIN THE LIMITS AS SET OUT UNDER (I) AND (II) OF THE SECOND PARAGRAPH ABOVE, FOR THE FOLLOWING OPERATIONS: 1. A CAPITAL INCREASE OR THE ISSUANCE OF CONVERTIBLE BONDS OR WARRANTS WITH CANCELLATION OR LIMITATION OF THE PREFERENTIAL SUBSCRIPTION RIGHTS OF THE EXISTING SHAREHOLDERS; 2. A CAPITAL INCREASE OR THE ISSUANCE OF CONVERTIBLE BONDS WITH CANCELLATION OR LIMITATION OF THE PREFERENTIAL SUBSCRIPTION RIGHTS OF THE EXISTING SHAREHOLDERS FOR THE BENEFIT OF ONE OR MORE SPECIFIC PERSONS WHO ARE NOT EMPLOYEES OF THE COMPANY OR OF ITS SUBSIDIARIES; 3. A CAPITAL INCREASE BY INCORPORATION OF RESERVES. ANY SUCH CAPITAL INCREASE MAY TAKE ANY AND ALL FORMS, INCLUDING, BUT NOT LIMITED TO, CONTRIBUTIONS IN CASH OR IN KIND, WITH OR WITHOUT SHARE PREMIUM, OR INCORPORATION OF RESERVES AND/OR SHARE PREMIUMS AND/OR PROFITS CARRIED FORWARD, TO THE MAXIMUM EXTENT PERMITTED BY THE LAW. ANY DECISION OF THE BOARD OF DIRECTORS TO USE THIS AUTHORIZATION REQUIRES A 75% MAJORITY WITHIN THE BOARD OF DIRECTORS. THIS AUTHORIZATION REQUIRES A 75% MAJORITY WITHIN THE BOARD OF DIRECTORS. THIS AUTHORIZATION IS GRANTED FOR A PERIOD OF TWO (2) YEARS AS FROM THE DATE OF THE PUBLICATION IN THE APPENDICES TO THE BELGIAN OFFICIAL GAZETTE OF THE RESOLUTION OF THE EXTRAORDINARY SHAREHOLDERS MEETING HELD ON 26 APRIL 2018. THE BOARD OF DIRECTORS IS EMPOWERED, WITH FULL POWER OF SUBSTITUTION, TO AMEND THE ARTICLES OF ASSOCIATION TO REFLECT THE CAPITAL INCREASES RESULTING FROM THE EXERCISE OF ITS POWERS PURSUANT TO THIS ARTICLE. |
|
Management |
|
For |
|
For |
|
|
|
AS PERSONS ACTING ON THEIR OWN BEHALF BUT FOR THE ACCOUNT OF THE COMPANY OR ITS DIRECT OR INDIRECT SUBSIDIARIES, CAN HOLD NO MORE THAN 10% OF THE TOTAL NUMBER OF SHARES ISSUED BY THE COMPANY AT THE MOMENT OF THE ACQUISITION CONCERNED. THIS AUTHORIZATION IS GRANTED FOR A PERIOD STARTING AS OF THE DATE OF THE GENERAL MEETING APPROVING IT AND EXPIRING ON 30 JUNE 2020. THE AUTHORIZATION GRANTED TO THE BOARD OF DIRECTORS PURSUANT TO THIS ARTICLE EXTENDS TO ANY ACQUISITIONS OF THE COMPANYS SHARES, DIRECTLY OR INDIRECTLY, BY THE COMPANYS DIRECT SUBSIDIARIES AS DEFINED IN ARTICLE 627 OF THE COMPANIES CODE. THIS AUTHORIZATION REPLACES AS OF THE DATE OF THE GENERAL MEETING APPROVING IT THE AUTHORIZATION GRANTED BY DECISION OF THE EXTRAORDINARY SHAREHOLDERS MEETING OF THE COMPANY HELD ON 28 APRIL 2016. AS THE CASE MAY BE, ANY DISPOSAL OF OWN SHARES BY THE COMPANY OR ITS DIRECT SUBSIDIARIES WILL BE MADE PURSUANT TO THE AUTHORIZATION GRANTED TO THE BOARD OF DIRECTORS AS SET FORTH IN ARTICLE 12 IN FINE OF THE ARTICLES OF ASSOCIATION OF THE COMPANY |
|
|
|
|
|
|
|
UNIQURE N.V.
Security |
N90064101 |
Meeting Type |
Special |
Ticker Symbol |
QURE |
Meeting Date |
14-Sep-2017 |
Record Date |
17-Aug-2017 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
APPOINTMENT OF JEREMY SPRINGHORN AS NON- EXECUTIVE DIRECTOR. |
|
Management |
|
For |
|
For |
|
2. |
|
APPOINTMENT OF MADHAVAN BALACHANDRAN AS NON-EXECUTIVE DIRECTOR. |
|
Management |
|
For |
|
For |
|
UNIQURE N.V.
Security |
N90064101 |
Meeting Type |
Annual |
Ticker Symbol |
QURE |
Meeting Date |
13-Jun-2018 |
Record Date |
16-May-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1. |
|
Resolution to adopt the 2017 annual accounts and treatment of the results. |
|
Management |
|
For |
|
For |
|
2. |
|
Resolution to discharge liability of the members of the Board for their management. |
|
Management |
|
For |
|
For |
|
3a. |
|
Appointment of Philip Astley-Sparke as non-executive director. |
|
Management |
|
For |
|
For |
|
3b. |
|
Appointment of Robert Gut as non-executive director. |
|
Management |
|
For |
|
For |
|
3c. |
|
Appointment of David Meek as non-executive director. |
|
Management |
|
For |
|
For |
|
4. |
|
Amendment to the 2014 Restated Plan. |
|
Management |
|
For |
|
For |
|
5. |
|
Resolution to designate the Board as the competent body to issue ordinary shares and options and to exclude preemptive rights under the 2014 Restated Plan. |
|
Management |
|
For |
|
For |
|
6. |
|
Approval of the employee share purchase plan. |
|
Management |
|
For |
|
For |
|
7. |
|
Resolution to redesignate the Board as the competent body to issue ordinary shares and options and to limit or exclude pre-emptive rights. |
|
Management |
|
For |
|
For |
|
8. |
|
Authorization of the Board to repurchase ordinary shares. |
|
Management |
|
For |
|
For |
|
9. |
|
Resolution to reappoint PricewaterhouseCoopers Accountants N.V. as auditor of the Company for the 2018 financial year ending at the close of the Annual General Meeting. |
|
Management |
|
For |
|
For |
|
UNITEDHEALTH GROUP INCORPORATED
Security |
91324P102 |
Meeting Type |
Annual |
Ticker Symbol |
UNH |
Meeting Date |
04-Jun-2018 |
Record Date |
10-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: William C. Ballard, Jr. |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Richard T. Burke |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Timothy P. Flynn |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Stephen J. Hemsley |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Michele J. Hooper |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: F. William McNabb III |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Valerie C. Montgomery Rice, M.D. |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Glenn M. Renwick |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Kenneth I. Shine, M.D. |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: David S. Wichmann |
|
Management |
|
For |
|
For |
|
1k. |
|
Election of Director: Gail R. Wilensky, Ph.D. |
|
Management |
|
For |
|
For |
|
2. |
|
Advisory approval of the Companys executive compensation. |
|
Management |
|
For |
|
For |
|
3. |
|
Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
VALEANT PHARMACEUTICALS INTERNATIONAL
Security |
91911K102 |
Meeting Type |
Annual |
Ticker Symbol |
VRX |
Meeting Date |
30-Apr-2018 |
Record Date |
05-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Richard U. DeSchutter |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: D. Robert Hale |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Dr. Argeris (Jerry) N. Karabelas |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Sarah B. Kavanagh |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Joseph C. Papa |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: John A. Paulson |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Robert N. Power |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Russel C. Robertson |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Thomas W. Ross, Sr. |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Amy B. Wechsler, M.D. |
|
Management |
|
For |
|
For |
|
2. |
|
The approval, in an advisory resolution, of the compensation of our Named Executive Officers as disclosed in the Compensation Discussion and Analysis section, executive compensation tables and accompanying narrative discussions contained in the Management Proxy Circular and Proxy Statement. |
|
Management |
|
For |
|
For |
|
3. |
|
The approval of an amendment to the Companys 2014 Omnibus Incentive Plan to increase the number of Common Shares authorized under such plan. |
|
Management |
|
Against |
|
Against |
|
4. |
|
To appoint PricewaterhouseCoopers LLP as the auditors for the Company to hold office until the close of the 2019 Annual Meeting of Shareholders and to authorize the Companys Board of Directors to fix the auditors remuneration. |
|
Management |
|
For |
|
For |
|
VENTAS, INC.
Security |
92276F100 |
Meeting Type |
Annual |
Ticker Symbol |
VTR |
Meeting Date |
15-May-2018 |
Record Date |
16-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1A. |
|
Election of Director: Melody C. Barnes |
|
Management |
|
For |
|
For |
|
1B. |
|
Election of Director: Debra A. Cafaro |
|
Management |
|
For |
|
For |
|
1C. |
|
Election of Director: Jay M. Gellert |
|
Management |
|
For |
|
For |
|
1D. |
|
Election of Director: Richard I. Gilchrist |
|
Management |
|
For |
|
For |
|
1E. |
|
Election of Director: Matthew J. Lustig |
|
Management |
|
For |
|
For |
|
1F. |
|
Election of Director: Roxanne M. Martino |
|
Management |
|
For |
|
For |
|
1G. |
|
Election of Director: Walter C. Rakowich |
|
Management |
|
For |
|
For |
|
1H. |
|
Election of Director: Robert D. Reed |
|
Management |
|
For |
|
For |
|
1I. |
|
Election of Director: James D. Shelton |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification of the selection of KPMG LLP as the independent registered public accounting firm for fiscal year 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory vote to approve our executive compensation. |
|
Management |
|
For |
|
For |
|
VERONA PHARMA PLC
Security |
GB00BYW2KH80 |
Meeting Type |
Annual General Meeting |
Ticker Symbol |
VRP |
Meeting Date |
02-May-2018 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1 |
|
TO RECEIVE AND ADOPT THE REPORT OF THE DIRECTORS AND THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2017 |
|
Management |
|
For |
|
For |
|
2 |
|
TO APPROVE THE DIRECTORS REMUNERATION POLICY |
|
Management |
|
For |
|
For |
|
3 |
|
TO APPROVE THE DIRECTORS REMUNERATION REPORT |
|
Management |
|
For |
|
For |
|
4 |
|
TO RE-ELECT DAVID RAYMOND EBSWORTH AS A DIRECTOR OF THE COMPANY |
|
Management |
|
For |
|
For |
|
5 |
|
TO RE-ELECT SVEN ANDERS ULLMAN AS A DIRECTOR OF THE COMPANY |
|
Management |
|
For |
|
For |
|
6 |
|
TO APPOINT PRICEWATERHOUSECOOPERS LLP AS AUDITORS |
|
Management |
|
For |
|
For |
|
7 |
|
TO AUTHORISE THE DIRECTORS TO DETERMINE THE AUDITORS REMUNERATION |
|
Management |
|
For |
|
For |
|
8 |
|
TO AUTHORISE THE DIRECTORS TO ALLOT RELEVANT SECURITIES PURSUANT TO SECTION 551 OF THE COMPANIES ACT 2006 |
|
Management |
|
For |
|
For |
|
9 |
|
TO AUTHORISE THE DIRECTORS TO ALLOT EQUITY SECURITIES PURSUANT TO SECTION 570 OF THE COMPANIES ACT 2006 |
|
Management |
|
For |
|
For |
|
VERONA PHARMA PLC
Security |
925050106 |
Meeting Type |
Annual |
Ticker Symbol |
VRNA |
Meeting Date |
02-May-2018 |
Record Date |
06-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
O1 |
|
To receive and adopt the report of the directors and the financial statements for the year ended 31 December 2017. |
|
Management |
|
For |
|
N/A |
|
O2 |
|
To approve the Directors Remuneration Policy. |
|
Management |
|
For |
|
N/A |
|
O3 |
|
To approve the Directors Remuneration Report. |
|
Management |
|
For |
|
N/A |
|
O4 |
|
To re-elect David Raymond Ebsworth as a director of the Company. |
|
Management |
|
For |
|
N/A |
|
O5 |
|
To re-elect Sven Anders Ullman as a director of the Company. |
|
Management |
|
For |
|
N/A |
|
O6 |
|
To appoint PricewaterhouseCoopers LLP as auditors. |
|
Management |
|
For |
|
N/A |
|
O7 |
|
To authorise the directors to determine the auditors remuneration. |
|
Management |
|
For |
|
N/A |
|
O8 |
|
To authorise the directors to allot relevant securities pursuant to Section 551 of the Companies Act 2006. |
|
Management |
|
For |
|
N/A |
|
S9 |
|
To authorise the directors to allot equity securities pursuant to Section 570 of the Companies Act 2006. |
|
Management |
|
For |
|
N/A |
|
VERONA PHARMA PLC
Security |
GB00BYW2KH80 |
Meeting Type |
Ordinary General Meeting |
Ticker Symbol |
VRP |
Meeting Date |
26-Jun-2018 |
Record Date |
N/A |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1 |
|
TO AUTHORISE THE DIRECTORS TO ALLOT RELEVANT SECURITIES PURSUANT TO SECTION 551 OF THE COMPANIES ACT 2006 |
|
Management |
|
For |
|
For |
|
2 |
|
TO AUTHORISE THE DIRECTORS TO ALLOT EQUITY SECURITIES AND/OR SELL TREASURY SECURITIES FOR CASH PURSUANT TO SECTION 570 AND 573 OF THE COMPANIES ACT 2006 |
|
Management |
|
For |
|
For |
|
VERONA PHARMA PLC
Security |
925050106 |
Meeting Type |
Annual |
Ticker Symbol |
VRNA |
Meeting Date |
26-Jun-2018 |
Record Date |
24-May-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
O1. |
|
To authorise the directors to allot relevant securities pursuant to Section 551 of the Companies Act 2006. |
|
Management |
|
For |
|
N/A |
|
S2. |
|
To authorise the directors to allot equity securities and/or sell treasury securities for cash pursuant to Section 570 and 573 of the Companies Act 2006. |
|
Management |
|
For |
|
N/A |
|
VERTEX PHARMACEUTICALS INCORPORATED
Security |
92532F100 |
Meeting Type |
Annual |
Ticker Symbol |
VRTX |
Meeting Date |
17-May-2018 |
Record Date |
29-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1.1 |
|
Election of Class I Director: Sangeeta N. Bhatia |
|
Management |
|
For |
|
For |
|
1.2 |
|
Election of Class I Director: Jeffrey M. Leiden |
|
Management |
|
For |
|
For |
|
1.3 |
|
Election of Class I Director: Bruce I. Sachs |
|
Management |
|
For |
|
For |
|
2. |
|
Amendments to our charter and by-laws to eliminate supermajority provisions. |
|
Management |
|
For |
|
For |
|
3. |
|
Amendment and restatement of our 2013 Stock and Option Plan, to among other things, increase the number of shares available under the plan by 8.0 million shares. |
|
Management |
|
For |
|
For |
|
4. |
|
Ratification of Ernst & Young LLP as our Independent Registered Public Accounting firm for the year ending December 31, 2018. |
|
Management |
|
For |
|
For |
|
5. |
|
Advisory vote on named executive officer compensation. |
|
Management |
|
For |
|
For |
|
6. |
|
Shareholder proposal, if properly presented at the meeting, requesting that we prepare a report on the risks to us of rising drug prices. |
|
Shareholder |
|
Against |
|
For |
|
7. |
|
Shareholder proposal, if properly presented at the meeting, requesting that we prepare a report on our policies and activities with respect to lobbying. |
|
Shareholder |
|
Against |
|
For |
|
WELLTOWER INC.
Security |
95040Q104 |
Meeting Type |
Annual |
Ticker Symbol |
WELL |
Meeting Date |
03-May-2018 |
Record Date |
06-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Kenneth J. Bacon |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Thomas J. DeRosa |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Jeffrey H. Donahue |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Geoffrey G. Meyers |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Timothy J. Naughton |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Sharon M. Oster |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Judith C. Pelham |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Sergio D. Rivera |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: R. Scott Trumbull |
|
Management |
|
For |
|
For |
|
1j. |
|
Election of Director: Gary Whitelaw |
|
Management |
|
For |
|
For |
|
2. |
|
The ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
The approval, on an advisory basis, of the compensation of our named executive officers as disclosed in the 2018 Proxy Statement. |
|
Management |
|
For |
|
For |
|
4. |
|
The approval of the Welltower Inc. Employee Stock Purchase Plan. |
|
Management |
|
For |
|
For |
|
WRIGHT MEDICAL GROUP N V
Security |
N96617118 |
Meeting Type |
Annual |
Ticker Symbol |
WMGI |
Meeting Date |
29-Jun-2018 |
Record Date |
01-Jun-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Appointment of Robert J. Palmisano for executive director. Mark For to appoint Palmisano. |
|
Management |
|
For |
|
For |
|
1b. |
|
Appointment of David D. Stevens for non-executive director. Mark For to appoint Stevens. |
|
Management |
|
For |
|
For |
|
1c. |
|
Appointment of Gary D. Blackford for non-executive director. Mark For to appoint Blackford. |
|
Management |
|
For |
|
For |
|
1d. |
|
Appointment of J. Patrick Mackin for non-executive director. Mark For to appoint Mackin. |
|
Management |
|
For |
|
For |
|
1e. |
|
Appointment of John L. Miclot for non-executive director. Mark For to appoint Miclot. |
|
Management |
|
For |
|
For |
|
1f. |
|
Appointment of Kevin C. OBoyle for non-executive director. Mark For to appoint OBoyle. |
|
Management |
|
For |
|
For |
|
1g. |
|
Appointment of Amy S. Paul for non-executive director. Mark For to appoint Paul. |
|
Management |
|
For |
|
For |
|
1h. |
|
Appointment of Richard F. Wallman for non-executive director. Mark For to appoint Wallman. |
|
Management |
|
For |
|
For |
|
1i. |
|
Appointment of Elizabeth H. Weatherman for non- executive director. Mark For to appoint Weatherman. |
|
Management |
|
For |
|
For |
|
2. |
|
Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 30, 2018. |
|
Management |
|
For |
|
For |
|
3. |
|
Appointment of KPMG N.V. as the auditor for our Dutch statutory annual accounts for the fiscal year ending December 30, 2018. |
|
Management |
|
For |
|
For |
|
4. |
|
Adoption of our Dutch statutory annual accounts for the fiscal year ended December 31, 2017. |
|
Management |
|
For |
|
For |
|
5. |
|
Release of each member of our board of directors from liability with respect to the exercise of his or her duties during the fiscal year ended December 31, 2017. |
|
Management |
|
For |
|
For |
|
6. |
|
Extension of the authority of our board of directors to repurchase up to 10% of our issued share capital (including depositary receipts issued for our shares) until December 29, 2019 on the open market, through privately negotiated transactions or in one or more self- tender offers for a price per share (or depositary receipt) not less than the nominal value of a share and not higher than 110% of the market price of a share (or depositary receipt) at the time of the transaction. |
|
Management |
|
For |
|
For |
|
7. |
|
Approval, on an advisory basis, of our executive compensation. |
|
Management |
|
For |
|
For |
|
XENON PHARMACEUTICALS INC
Security |
98420N105 |
Meeting Type |
Annual |
Ticker Symbol |
XENE |
Meeting Date |
04-Jun-2018 |
Record Date |
09-Apr-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
| |
1. |
|
DIRECTOR |
|
Management |
|
|
|
|
| |
|
|
1 |
Michael Tarnow |
|
|
|
For |
|
For |
|
|
|
2 |
Mohammad Azab |
|
|
|
For |
|
For |
|
|
|
3 |
Steven Gannon |
|
|
|
For |
|
For |
|
|
|
4 |
Michael Hayden |
|
|
|
For |
|
For |
|
|
|
5 |
Frank Holler |
|
|
|
For |
|
For |
|
|
|
6 |
Gary Patou |
|
|
|
For |
|
For |
|
|
|
7 |
Simon Pimstone |
|
|
|
For |
|
For |
|
|
|
8 |
Richard Scheller |
|
|
|
For |
|
For |
|
|
|
9 |
Dawn Svoronos |
|
|
|
For |
|
For |
|
2. |
|
Appointment of KPMG LLP as Auditor |
|
Management |
|
For |
|
For |
| |
3. |
|
Authorizing the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the Auditor |
|
Management |
|
For |
|
For |
|
ZIMMER BIOMET HOLDINGS, INC.
Security |
98956P102 |
Meeting Type |
Annual |
Ticker Symbol |
ZBH |
Meeting Date |
15-May-2018 |
Record Date |
16-Mar-2018 |
|
|
Item |
|
Proposal |
|
Proposed |
|
Vote |
|
For/Against |
|
1a. |
|
Election of Director: Christopher B. Begley |
|
Management |
|
For |
|
For |
|
1b. |
|
Election of Director: Betsy J. Bernard |
|
Management |
|
For |
|
For |
|
1c. |
|
Election of Director: Gail K. Boudreaux |
|
Management |
|
For |
|
For |
|
1d. |
|
Election of Director: Michael J. Farrell |
|
Management |
|
For |
|
For |
|
1e. |
|
Election of Director: Larry C. Glasscock |
|
Management |
|
For |
|
For |
|
1f. |
|
Election of Director: Robert A. Hagemann |
|
Management |
|
For |
|
For |
|
1g. |
|
Election of Director: Bryan C. Hanson |
|
Management |
|
For |
|
For |
|
1h. |
|
Election of Director: Arthur J. Higgins |
|
Management |
|
For |
|
For |
|
1i. |
|
Election of Director: Michael W. Michelson |
|
Management |
|
For |
|
For |
|
2. |
|
Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2018 |
|
Management |
|
For |
|
For |
|
3. |
|
Advisory vote to approve named executive officer compensation (Say on Pay) |
|
Management |
|
For |
|
For |
|
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) |
Tekla World Healthcare Fund |
| ||
|
| |||
By (Signature and Title)* |
| |||
|
| |||
|
/s/ Daniel R. Omstead |
| ||
|
(Daniel R. Omstead, President) | |||
|
| |||
Date |
8/21/18 |
| ||
*Print the name and title of each signing officer under his or her signature.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- More Drivers Are Underinsured on the Nation’s Roads, According to New IRC Study
- L.L.Bean and Summersalt Launch New Limited Edition Summer Collaboration
- Domestic Violence Survivor Publishes An Encouraging Book About Recognizing And Healing Past Trauma, Finding Strength And Inspiration From God's Unconditional Love, And The Hidden Power Uncovered
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!